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Proteins are complex biomacromolecules playing fundamental roles in the
physiological processes of all living organisms. They function as structural units,
enzymes, transporters, process regulators, and signal transducers. Defects in protein
functions often derive from genetic mutations altering the protein structure, and
impairment of essential protein functions manifests itself as pathological conditions.
Proteins operate through interactions, and all protein functions depend on protein
structure. In order to understand biological mechanisms at the molecular level, one
has to know the structures of the proteins involved.
This thesis covers structural and functional characterization of human
filamins. Filamins are actin-binding and -bundling proteins that have numerous
interaction partners. In addition to their actin-organizing functions, filamins are also
known to have roles in cell adhesion and locomotion, and to participate in the
logistics of cell membrane receptors, and in the coordination of intracellular
signaling pathways. Filamin mutations in humans induce severe pathological
conditions affecting the brain, bones, limbs, and cardiovascular system. Filamins
are large modular proteins composed of an N-terminal actin-binding domain and 24
consecutive immunoglobulin-like domains (IgFLNs).
Nuclear magnetic resonance (NMR) spectroscopy is a versatile method of
gaining insight into protein structure, dynamics and interactions. The latest
advancements in this technique enable the efficient characterization of multi-
domain proteins, which are challenging targets due to their large size and dynamic
behavior. NMR spectroscopy was employed in this thesis to study the atomic
structure and interaction mechanisms of C-terminal IgFLNs, which are known to
house the majority of the filamin interaction sites.
The structures of IgFLN domains 17 (I) and 23 (II) were determined using
NMR spectroscopy. NMR spectroscopy was also employed to characterize the
interactions of domains 17 and 23 with glycoprotein Ib  and FilGAP, respectively.
The structures of IgFLN domain pairs 16–17 and 18–19 (III, IV) both revealed
novel domain–domain interaction modes of IgFLNs. The interaction of IgFLN
domain 19 with integrin 7 and dopamine receptors was studied using NMR
titrations. Domain packing of IgFLN domain sextet 16–21 was further characterized
using residual dipolar couplings and NMR relaxation analysis (V). This thesis
demonstrates the versatility and potential of NMR spectroscopy in structural and
functional studies of multi-domain proteins.
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“Almost all aspects of life are engineered
at the molecular level, and without
understanding molecules we can only have
a very sketchy understanding of life itself.”





This thesis gives an overview of modern biomolecular nuclear magnetic resonance
(NMR) spectroscopy and its potential in structural and functional studies of multi-
domain proteins. The original publications included in this thesis deal with the
structure and interactions of the immunoglobulin-like domains of human filamin A
(IgFLNa). The experimental part of the thesis summarizes the results of the original
research papers and also presents some unpublished results closely related to the
topic.
As an introduction to the experimental part, the text begins with a broad
literature review. The review is divided into three separate chapters: (i) multi-
domain proteins; (ii) filamins; and (iii) NMR spectroscopy of multi-domain
proteins. The first chapter introduces general aspects of protein structure and
modularity of proteins. As filamin is the target protein of the experimental part of
the study its structure, function and biological role are presented in detail in the
second chapter. The third introductory chapter covers the latest advances in protein
NMR spectroscopy. As multi-domain proteins are usually rather large molecular
systems, specialized NMR methods are needed in their studies. The NMR
techniques employed in studies of large protein systems will be thus covered in
more detail.
The original research papers contain results obtained using a range of
experimental techniques: biochemical and whole cell experiments, molecular
modeling, small-angle X-ray scattering (SAXS), electron microscopy, X-ray
crystallography and NMR spectroscopy. The experimental summary of this thesis





All life, as we know it on earth, depends on proteins. Proteins are complex
biomacromolecules playing fundamental roles in the physiological processes of all
living organisms. They make most of the cellular machinery by serving as structural
units, enzymes, transporters, regulators and signal transducers. Information on the
protein assembly of an organism is coded in the DNA sequence. Nucleotide
sequences of genes code for protein sequences. The genetic information is first
transcribed into mRNA which is transported from nucleus to cytosol and then
transcribed to protein sequences at the ribosomes. Via complicated folding
pathways, protein sequences form delicate three-dimensional architectures that
break up easily through denaturation. Proteins function through interactions—they
can interact with other proteins, nucleic acids, carbohydrates, lipid membranes and
small molecules, e.g., neurotransmitters and drugs (Keskin et al. 2008). These
interactions are specific and proteins recognize their binding partners with great
fidelity. Protein interactions and function depends on their structure. The structure
of a protein determines its function, and flaws in protein function also derive from
its structure. Since protein structure is such an essential part of life, it is important to
know and understand structures of proteins in great detail.
2.1. Protein Structure
Protein structure is often described using four levels of structural organization:
primary, secondary, tertiary and quaternary structure (Fig. 1). Primary structure of
a protein, i.e., the amino acid sequence, determines the higher-order structure of the
protein. Secondary structure is formed through and defined by hydrogen bond
patterns of the protein backbone. The most common secondary structure elements
are  helix and antiparallel  strand, but also other structures such as parallel 
strands, 310 helix,  helix and polyproline II helix are often found. Around 2/3 of the
protein sequence is arranged into regular secondary structure elements; the
remainder consists of loops, turns and coils. Tertiary structure is the spatial folding
pattern of the entire polypeptide chain. The fold of a protein describes the number
and the arrangement of the secondary structural elements in a protein. Tertiary
structure is formed through non-covalent forces—ion/dipole interactions, hydrogen
bonds, van der Waals forces, and the hydrophobic effect—which in principle tend
to bury hydrophobic residues inside the structure while retaining hydrophilic ones at
the surface. Covalent disulfide bridges also contribute to the formation of tertiary
structure. Even if protein fold is determined by the protein sequence, folding is an
extremely complex process and at the moment no efficient computational methods
exist to determine the protein fold directly from the amino acid sequence. Some
proteins are intrinsically disordered and attain the folded state only in complexes
with their physiological targets (Wright and Dyson 2009). Quaternary structure is
formed when several polypeptide chains (subunits) join together in order to make
up a fully functional homo-oligomer. However, protein structure categorization is
not quite as simple as this, since several intermediate levels of structural
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organization exist (Caetano-Anollés et al. 2009). Supersecondary structures are
recurrent patterns of secondary structure elements that are encountered in many
structures. Domains are to some extent independent subunits of tertiary structure,
having an isolated hydrophobic core, and they are an especially important level of
organization when describing the structure of modular multi-domain proteins. There
are also higher levels of structural organization to quaternary structure. Many
proteins form multi-protein complexes where subunits carry out their functions
cooperatively. Multi-enzyme complexes, e.g., tryptophan synthase (Barends et al.
2008), are excellent examples of functional protein complexes co-localizing several
processes of complicated biological pathways (Srere 1987). Many proteins go
through post-translational modifications; e.g., proteolytic processing, glycosylation
and phosphorylation; which can alter their structure and function (Kyte 2007, p.
113–125). One has to also keep in mind that protein structure is not as solid as a
rock but proteins are dynamic entities and internal motions are frequently involved
in protein function (McCammon and Harvey 1988; Kern and Zuiderweg 2003;
Tousignant and Pelletier 2004).
Fig. 1 The protein structure organization levels represented using F1 ATPase as
an example. Reprinted with permission from (Caetano-Anollés et al. 2009). © 2009
the Biochemical Society.
2.1.1. Protein Domains: Immunoglobulin-like Domains
Protein domains, or modules, are generally regarded as rather independent
structural components of proteins that can often be expressed as a single isolated
unit (Han et al. 2007). However, protein domain can be understood and defined in
several different ways: functional domains, sequence domains, evolutionary
domains, structural domains or domains as independent folding units (Majumdar et
al. 2009). It has been noted that the domain structure is more strongly conserved in
evolution than protein sequence (Chothia and Lesk 1986) and sequentially rather
distant polypeptides can have similar folds. This is obviously an indication of
conservation of protein function which is determined by its structure. Some proteins
have only one domain, whereas others can have dozens or even hundreds of
domains, such as giant muscle protein titin (Labeit and Kolmerer 1995), which is
the largest protein known so far. Protein domains serve for several different
purposes: they can have structural, enzymatic and interactive roles. Some domains
function as spacers between other domains, placing them in optimal spatial
orientation for their function. Enzymatic domains perform catalytic reactions.
Domains mediating interactions can bind other proteins, nucleic acids, lipids and
membranes, carbohydrates and small ligands. Protein–protein interaction domains
Multi-domain proteins
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are specified to recognize protein surfaces based on their shape and charge
distribution. Enzymes can have separate domains for enzymatic activity; i.e.,
binding and processing of the substrate; and binding of activity modulators.
Transcription factors bind to their target genes using specific DNA sequence-
recognizing and -binding domains. Some domains anchor proteins to membranes.
Protein structure classification databases, e.g., SCOP and CATH (Murzin et al.
1995; Orengo et al. 1997), catalog hundreds of different domains or fold
superfamilies, but there is no purpose in repeating the list here. To give examples of
protein domains, Table 1 presents an overview of frequently encountered domains
participating in protein interactions.
Table 1 Overview of common protein domains having roles in protein interactions
(adapted from Kyte 2007, p. 386). ,  helix; ,  strand; L, loop; RC, random coil;
Ccyn, n cystine bridges.
Domain Approximate length Structure Function
EF hand 40 Calcium binding
Immunoglobulin 100 7 Protein–protein interaction
Leucine-rich repeat 30 )n Protein–protein interaction
RNA recognition motif 80 2 RNA binding
EGF 50 RC(Ccy3-4) Protein–protein interaction
Cohesin 140 9 Protein–protein interaction
Ankyrin 40 2 2)n Protein–protein interaction
C2 120 8 Calcium and membrane binding
SH2 100 5 Protein binding through pTyr
SH3 60 5 Protein–protein interaction
Kringle 80 RC(Ccy3) Protein–protein interaction
SAND 80 2 2 2 DNA binding
Pleckstrin homology 100 7 Lipid/membrane binding
Fibronectin type I 50 5 Protein–protein interaction
Fibronectin type II 60 3 Protein–protein interaction
Armadillo 50 3 Protein–protein interaction
Fibronectin type III 90 7 Protein–protein interaction
START 200 3 2 6 Lipid binding
Hemopexin 200 Four-bladed  propeller Protein–protein interaction
Immunoglobulin-like Domains
The immunoglobulin-like (Ig) domain, i.e., a protein domain with an
immunoglobulin-like fold, is one of the most widespread protein modules (Williams
and Barclay 1988; Bork et al. 1994; Halaby and Mornon 1998; Barclay 2003;
Gelfand et al. 2007). Ig domain was first observed in proteins of the immune
system, from whence it got its name, but later Ig domains have been found in
proteins with diverse functions. Ig domains are most often encountered in cell
adhesion molecules (Aricescu and Jones 2007) and in structural proteins of the
cytoskeleton, especially in sarcomeres (Pinotsis et al. 2009), but also in membrane
receptors, e.g., receptor tyrosine kinases (Wiesmann et al. 2000). Usually Ig
domains serve structural and binding roles—no enzymatic activity has been
observed for natural Ig domains. Ig domains are often part of multi-domain
proteins, either as repeats of Ig domains or combined with other domain types.
Sequences of Ig domains are remarkably divergent and structures also vary
considerably, but some similarities can still be found (Halaby et al. 1999). Ig
Multi-domain proteins
5
domain is composed of around 100 amino acid residues and it belongs to class of
all-  proteins. Ig fold is a  sandwich of two  sheets. Conventional topology
contains seven  strands but some forms have additional strands up to total of 10. 
strands are named in alphabetical order starting from N-terminus. Traditionally, Ig
folds are divided into four structural sets; V-, C1-, C2- and I-type Ig folds;
according to their topologies (Fig. 2), but also other more detailed categories have
been proposed (Bork et al. 1994; Halaby et al. 1999). In addition to the  sandwich
fold there are other partly conserved features in the structures of Ig domains. Many
Ig domains of extracellular proteins have a disulfide bridge between strands B and F
and a tryptophan residue located at the strand C is an essential part of the
hydrophobic core of many Ig domains (Chothia et al. 1998). Hemmingsen et al.
have identified the so-called tyrosine corner as an important structural feature of
several Ig domains (Hemmingsen et al. 1994).
Multi-domain proteins
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Fig. 2 The traditional topological classes (I, C1, V and C2) of Ig domains.
Nomenclature of the  strands is shown with small capital letters. Closed circle, 
sheet residue; open circle, loop residue having conserved conformation; dashed
lines, hydrogen bonds; diamond, location of highly conserved cysteine residues.
PDB codes of the example structures: I, 2YXM; C1, 1X7Q; V, 1UZ8; C2, 2D9Q.
Reprinted and adapted with permission from (Gelfand et al. 2007). © 2007 John




There are several examples of proteins that are made of only a single domain but
around two-thirds of proteins contain multiple domains, i.e., they are multi-domain
or modular proteins. Structure, function and evolution of multi-domain proteins
have been recently reviewed by Vogel et al. and Han et al. (Vogel et al. 2004a; Han
et al. 2007). About 20% of proteins contain tandem domain repeats but more often
multi-domain proteins are combinations of different types of domains. Architecture
of multi-domain protein describes the domain content of the protein in N- to C-
terminal order. Protein domains are traditionally seen as structurally and
functionally independent units but this is not necessarily the case in multi-domain
proteins. Domain structures might mold at the domain interfaces or the structure of
a domain might be entirely different in different domain combinations. Sometimes
it is difficult to clearly determine the domain boundaries without knowledge of the
structure of the entire unit (Holland et al. 2006).
There are several databases, e.g., SCOP and CATH, for protein fold
classification (Hadley and Jones 1999). SCOP (structural classification of proteins)
categorizes proteins according to class, fold, superfamily and family (Murzin et al.
1995) whereas CATH classifies structures of protein domains according to class,
architecture, topology and homologous superfamily (Orengo et al. 1997). These
classification schemes overlap but also have some differences. Many protein
comparison tools rely on sequence alignment, i.e., comparison of primary structure,
but there are also tools e.g., DALI (Holm and Sander 1998) for 3D structural
alignment (Hasegawa and Holm 2009). The latest CATH release (CATH version
3.2) contains over 2000 homologous domain superfamilies (Cuff et al. 2009). After
decades of protein sequence analysis and structure determination, it has become
evident that variation in the level of protein folds is limited and it has been
speculated that our knowledge of single-domain folds is almost complete (Levitt
2009).
In the case of modular proteins, the domain boundaries and folds are not
always straightforward to predict and determine. Sippl has recently reviewed
protein structures with unconventional domain constructions (Sippl 2009).
Although SCOP database is a good collection of clear cut domains encountered in
proteins and it also contains specific class for multi-domain proteins (Murzin et al.
1995), a specific domain definition database has been created for multi-domain
proteins with complex inter-domain geometry (Majumdar et al. 2009). Relative to
each other, modules can be rigid or flexible. During protein function structures of
individual modules usually stay unchanged while protein as a whole can undergo
large shape changes (Gerstein et al. 1994). In addition, the assumption that the
domain is an autonomous folding unit can be misleading, as adjacent domains
might affect each other’s folding and even structure (Han et al. 2007). Folding of
domains in multi-domain proteins can be different from isolated domains (Batey et
al. 2005; Fitter 2009). Yet most of the folding studies have been conducted on small
globular proteins containing a single domain. There are some excellent examples of
experimental folding studies of multi-domain constructs; for example Hsu et al.
have studied the folding of tandem Ig domain protein using NMR spectroscopy
(Hsu et al. 2007).
Multi-domain proteins
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Multi-functionality of proteins with multiple domains was recognized
several decades ago (Kirschner and Bisswanger 1976). Domains of a modular
protein can function cooperatively, e.g., active sites of enzymes, can sometimes
reside between domains or accessibility of the active site may be regulated by other
domains. Multi-enzyme synthases are multi-domain enzymes functioning as
molecular assembly lines that house several steps of biological pathways in the
same polypeptide (Hawkins and Lamb 1995; Weissman and Müller 2008; Meier
and Burkart 2009). Evolution of protein modularity has been recently reviewed
(Han et al. 2007; Trifonov and Frenkel 2009) and it has been noted that new protein
functions can evolve by combination of different domains (Bashton and Chothia
2007). Domain combination can, e.g., modify substrate binding or regulate enzyme
function, regulate DNA binding of transcription factors, generate multifunctional
enzymes, change the structural contexts of the function or even gain entirely new
catalytic activity.
To understand the function of a modular protein and the roles of the
individual domains, one needs to know the three-dimensional structure of the entire
system. Unfortunately, the majority of protein structures available to date in the
PDB database are single domains in isolation. Structure determination of modular
proteins is challenging due to their large size and dynamicity. Dynamicity poses a
problem in protein crystallization for X-ray crystallographic structure analysis and
large size complicates NMR spectroscopic structure determination. Sometimes,
especially when there is a strong interaction between the domains, heterologous
expression of the multi-domain protein might turn out to be difficult (Han et al.
2007). Modeling methods have been employed to predict the structures of multi-
domain proteins using predetermined structures of the sub-domains, which are often
easier to solve than the structure of the whole system (Wollacott et al. 2007). Vogel
et al. have identified especially abundant supra-domains, i.e., two- or three-domain
combinations that occur frequently in modular proteins, whose structure
determination should be given first priority (Vogel et al. 2004b).
2.2. Protein Structure Determination
The first step on the long road to solving the structure of a protein is determination
of its sequence. Protein sequencing can be done in several ways. Entire genomic
sequences of several organisms are readily available in public databases, and often
the most straightforward way to protein sequence is through the sequence of the
gene coding it; alternatively, if the DNA sequence is not yet available, through
sequencing of the DNA or the mRNA coding the protein. Proteins can be also
sequenced de novo (Findlay and Geisow 1989). Edman degradation (Edman 1950),
i.e., chemical sequencing of peptides and proteins, became available in the 1950s
and the method was soon automated. Edman degradation is still used in some cases,
but sequencing by mass spectrometry has largely replaced it (Standing 2003). Mass
spectrometry also gives detailed information on post-translational modifications of
the protein (Witze et al. 2007).
Even if the protein sequence determines the three-dimensional structure of
a  protein,  at  present,  it  is  not  feasible  to  predict  the  structure  and  function  of  a
protein de novo from the sequence alone—at least not efficiently. Sadowski and
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Jones have recently reviewed the attempts to reveal protein sequence–structure–
function relationships (Sadowski and Jones 2009). It has been demonstrated that
structures of small proteins can be modeled quite accurately directly from the
sequence, but these are still rare examples. Homology modeling is frequently used
to derive protein structures especially in drug discovery (Venselaar et al. 2009).
This method, however, requires a predetermined structure of a closely related
protein, which is not always available, and might produce deceptive results if a
template is used that is too distant. There is, therefore, a need for efficient and
accurate experimental methods to determine protein structures, especially now in
the post-genomic era when the number of structure determination targets is
expanding.
Two experimental methods are available to study the detailed atomic
structure of proteins: X-ray crystallography and NMR spectroscopy. X-ray
crystallography has been employed to determine the structures of
biomacromolecules for over five decades (Drenth 2007) and the majority of
structures in the PDB database are crystal structures. Bottleneck of X-ray
crystallographic structure determination is protein crystallization which, even if it
has been largely automated, can be rather laborious or, in some cases, turn out to be
practically impossible (Chayen and Saridakis 2008). Crystal structures have been
criticized for not representing the protein structure in the natural monomeric
solution environment. Still, crystallography is usually the most effective method of
protein structure determination in terms of time and money. NMR spectroscopy
enables protein structure determination both in solution and in solid state (Cavanagh
et al. 2007). The first NMR structure of a protein was solved 25 years ago
(Williamson et al. 1985). NMR spectroscopic protein structure determination is
rather time consuming, but NMR spectroscopy is a versatile tool which can be used
also in studies of protein dynamics and interactions (see Chapter 4 for further
details on protein NMR spectroscopy).
Traditional protein structure determination projects have largely focused on
rather small isolated protein domains. This is due to ease in crystallization and the
good NMR properties of these rigid structures. Keeping in mind that two-thirds of
proteins contain more than one domain and domains often affect each other,
structures of larger systems should also be studied. In principle, protein size does
not set up any limits for X-ray crystallography, but multi-domain systems are often
somewhat dynamic and thus difficult to crystallize. Size matters in NMR
spectroscopy and thus large modular structures have not been routinely tackled with
this method. There are also other methods of gaining low resolution structural
information on biomacromolecules. In the case of modular proteins, even low
resolution structural data may be very informative. Electron microscopy provides a
structural view of biomacromolecules which is close to atomic resolution (Jonic and
Vénien-Bryan 2009) and it is often used jointly with X-ray crystallography. Small-
angle X-ray and neutron scattering (SAXS and SANS, respectively) are also
frequently used in structural studies of macromolecular assemblies and modular
proteins (Petoukhov and Svergun 2007). These methods provide information on the
dimensions and shape of the molecules in solution state, and the data analysis is




Filamins are actin-binding, -cross-linking and -bundling proteins (van der Flier and
Sonnenberg 2001b). Filamin, or actin-binding protein as it was called at that time,
was identified in 1975 as high-molecular weight actin-binding protein of rabbit lung
macrophages (Hartwig and Stossel 1975) and chicken gizzard (Wang et al. 1975).
Within a couple of years, filamin was purified and characterized in more detail
(Shizuta et al. 1976; Wang 1977; Wang and Singer 1977; Wallach et al. 1978b).
Filamins were the first family of actin-binding proteins found outside muscle cells.
Soon after their discovery, filamins were also identified in many other organs and
tissues such as skeletal and smooth muscle (Bechtel 1979; Koteliansky et al. 1981b;
Small et al. 1986) and heart (Koteliansky et al. 1981a; Koteliansky et al. 1986). In
addition to vertebrate filamins, filamin-related proteins were later found in several
other organisms, e.g., in Dictyostelium discoideum, Drosophila melanogaster,
Entamoeba histolytica and Caenorhabditis elegans. This review will be confined to
human filamins, but some examples of studies made on other vertebrates and
structural studies of Dictyostelium filamins will be included.
Three filamin isoforms have been identified in humans: filamin A (FLNa),
filamin B (FLNb) and filamin C (FLNc). Alphabetical naming is the most common
but sometimes, especially in the past, other naming systems have also been used
(Table 2) (van der Flier and Sonnenberg 2001b). FLNa isoform was the first one
found, and early literature does not clearly differentiate between the isoforms.
FLNb and FLNc were identified as different isoforms about two decades later
(Maestrini et al. 1993; Takafuta et al. 1998; Xu et al. 1998). Kesner et al. have
recently studied the phylogeny and molecular evolution of filamin isoforms using
sequence alignment (Kesner et al. 2009b). The three isoforms have emerged
through gene duplication and FLNc has diverged least from the common ancestor.
Table 2 Nomenclature of filamin isoforms
Filamin isoform Other names
Filamin A (FLNa) -filamin, actin-binding protein, ABP-280, FLN1
Filamin B (FLNb) -filamin, ABP-278, ABP-276, FLN3
Filamin C (FLNc) -filamin, ABPL, FLN2
FLNa and FLNb are the most ubiquitously expressed isoforms present in
most tissues and organs, while expression of FLNc is mainly restricted to striated
and cardiac muscle (Thompson et al. 2000). Chiang et al. have studied the
expression of filamin isoform genes in mouse embryos and expression of FLNa and
FLNb seems to be especially active in organs with a high proportion of epithelial
and smooth muscle cells, whereas expression of FLNc is largely localized into
striated and cardiac muscles during development (Chiang et al. 2000). Filamins,
especially FLNa and FLNb, seem to have somewhat overlapping tissue and cell
distribution. Different isoforms presumably have partially complementary roles and
they can compensate for each other (Feng and Walsh 2004; Baldassarre et al. 2009).
In cells, filamins are mostly located at peripheral cytoplasm and FLNc is located at
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the Z-discs of myofibrils (Maestrini et al. 1993). Normally intracellular filamins
have also been detected at the cell surface of several human cell lines (Bachmann et
al. 2006) and recently, even a secreted variant of FLNa was observed in the plasma
of cancer patients (Alper et al. 2009).
Filamin genes are located in different chromosomes: FLNa gene is mapped
to chromosome Xq28 (Maestrini et al. 1993; Fox et al. 1998), FLNb to 3p14.3
(Bröcker et al. 1999) and FLNc to 7q32–35 (Gariboldi et al. 1994). It should be
noted that inheritance of FLNa is X-linked. Filamin genes were sequenced in the
1990s (Xie et al. 1998) which enabled closer comparison of the different isoforms.
Protein sequence alignment shows that filamins share about 70% homology and are
presumed to be structurally very similar (van der Flier and Sonnenberg 2001b).
3.1. Physiological Implications
Filamins function in close collaboration with the cytoskeleton. The cytoskeleton is a
dynamic intracellular protein network that is responsible for cell shape, cell
adhesion, phagocytosis, locomotion, cell division, and for a range of other
fundamental cellular processes (Khurana 2006). Three types of protein filaments—
microfilaments, intermediate filaments and microtubules—form the mechanical
constructions of cytoskeleton. Microfilaments, also known as actin filaments and
thin filaments in muscle cells, are formed through polymerization of actin
monomers and are about 8 nm in diameter. Intermediate filaments have an average
diameter of 10 nm and are composed of ~70 filamentous proteins, e.g., keratin,
vimentin, desmin, neurofilaments and nuclear lamin (Szeverenyi et al. 2008).
Microtubules are hollow tubes with diameter of 25 nm formed through
polymerization of heterodimers of - and -tubulin. Actin filaments and
microtubules are polar structures polymerizing at the plus-end and depolymerizing
at the minus-end. Cytoskeleton is constantly reorganized and modified in structure.
Actin filaments, together with intermediate filaments and microtubules, form the
physical support structures of the cytoskeleton but they are accessorized with a
wide repertoire of other cytoskeletal proteins. Many of these proteins belong to a
protein class called actin-binding proteins (ABPs), which, as the name implies, are
able to bind actin. ABPs control polymerization and depolymerisation of the actin
filaments; they organize actin filaments into bundles and networks by cross-linking
several filaments together; they link the filaments to proteins of the cell membrane
and other cellular components; and they even participate in cellular signaling
cascades (Dos Remedios and Thomas 2001; Dos Remedios et al. 2003; Winder
2003; Winder and Ayscough 2005; Uribe and Jay 2009).
Filamins also belong to the group of cytoskeletal actin-binding proteins.
Filamins bind actin and bundle it into orthogonal networks or thick ropes depending
on the relative protein concentrations (Hartwig et al. 1980; Niederman et al. 1983).
Filamins contribute to cell morphology and movement and they are essential for
mammalian development. Cultured cells lacking filamin have unstable surfaces
exhibiting so-called blebbing, are incapable of locomotion and have impaired
mechanical resistance (Cunningham et al. 1992; Flanagan et al. 2001). Recent
results have shown that filamins play a role in initiation of cell migration and loss of
filamin does not, as such, alter cell speed (Baldassarre et al. 2009). Filamin gene
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knockout models have shed light on the roles and physiological importance of
different filamin isoforms. FLNa knockout mice have severe cardiac structural
defects leading to embryonic lethality (Feng et al. 2006; Hart et al. 2006). FLNb is
required in mice for skeletal and microvascular development (Lu et al. 2007; Zheng
et al. 2007; Zhou et al. 2007b) and FLNc is necessary for normal myogenesis
(Dalkilic et al. 2006)
Filamin mutations in humans cause a variety of developmental
malformations affecting mainly the brain, bone, limbs and the cardiovascular
system (Feng and Walsh 2004; Zhou et al. 2007a). Even small deletions and point
mutations in filamins lead to diverse congenital anomalies (Robertson 2004;
Robertson 2005). Table 3 recapitulates human diseases shown to be associated with
filamin mutations. Null mutations of FLNa lead to defects in neuronal migration,
vascular function, and connective tissue integrity (Fox et al. 1998; Parrini et al.
2006). Missense mutations in FLNa are linked to skeletal abnormalities and they are
suggested to be gain-of-function mutations (Robertson et al. 2003; Robertson
2007). It should be noted that as FLNa gene is located at the X chromosome,
mutations blocking the expression of functional FLNa often lead to embryonic
death in males. FLNb mutations disrupt bone morphogenesis (Krakow et al. 2004).
Mutations in FLNc are manifested as myofibrillar myopathies (Shatunov et al.
2009). In light of the different filamin-associated diseased, filamins seem to have




Table 3 Filamin mutation-associated human disorders.
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3.2. Structure of Filamins
Filamins are large homodimeric multi-domain proteins. Molecular weights of
FLNa, FLNb and FLNc are 280 kDa, 278 kDa and 290 kDa, respectively. When
FLNa sequence was first analyzed in detail (Gorlin et al. 1990), it was noted that
the structure contained an N-terminal actin-binding domain (ABD) and 24 tandem
immunoglobulin-like domains (IgFLNs), also called Ig repeats (Fig. 3). Filamins
form non-covalent tail-to-tail homodimers through the 24th IgFLN domain (Hartwig
and Stossel 1981; Pudas et al. 2006). ABD resembles -actinin and spectrin ABDs
with two calponin homology (CH) domains CH1 and CH2. IgFLNs 1–15 and 16–24
form the rod domains 1 and 2, respectively. Linkers between the Ig domains are
short and proline rich except for the two flexible hinges, hinge 1 (H1) and hinge 2
(H2), that interrupt the series of Ig repeats. H1 is located between domains 15–16
and H2 between domains 23–24 and they are 27 and 35 residues in length,
respectively. Hinges are sequentially less conserved than other regions: they show
only 45% homology while there is 70% overall sequence homology between FLN
isoforms (van der Flier and Sonnenberg 2001b). Electron microscopic images of
FLNs show V-shaped flexible chains with an overall monomer length of ~80 nm
(Hartwig et al. 1980; Hartwig and Stossel 1981).
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Fig. 3 Schematic representation of filamin structure. Red ellipse, actin-binding
domain (ABD); rectangle, filamin-type Ig domain (IgFLN); cyan, rod domain 1;
green, rod domain 2; yellow, hinge 1 (H1); purple, hinge 2 (H2); pink, dimerization
domain.
Filamins are known to be selectively proteolyzed by several proteases and
some filamin functions are presumably regulated through proteolysis. Filamin
proteolysis was first studied by Davies et al. (Davies et al. 1978). The hinge regions
are susceptible to proteolysis by calpain (Guyon et al. 2003; Raynaud et al. 2006).
Elevated calpain 2 activity and increased levels of FLNa16–24 fragment have been
detected in patients with Marfan syndrome; a heritable disorder of connective tissue
affecting principally skeletal, ocular, and cardiovascular systems (Pilop et al. 2009).
C-terminal fragment of FLNa (IgFLNa16–24) is known to translocate to nucleus
and interact there with androgen receptor (Loy et al. 2003). Granzyme B and
caspase cleavage of FLN is detected in apoptotic cells (Browne et al. 2000). Protein
activity can also be regulated by targeting proteins for proteasomal degradation.
ASB2 has been shown to target FLNa and FLNb for proteasomal degradation in
leukemia cells (Heuze et al. 2008). Filamin function can be regulated by alternative
splicing and several splicing variants of filamins have been identified (Maestrini et
al. 1993; Patrosso et al. 1994; Xie et al. 1998; van der Flier et al. 2002). Filamins
are also likely to be regulated by phosphorylation. Filamin phosphorylation was
studied soon after protein identification by Wallach and coworkers (Wallach et al.
1978a). Filamin is known to be phosphorylated by several kinases (see Table 5) and
Ser2152 of FLNa is one of the frequently encountered target residues.
Phosphorylation seems to inhibit filamin proteolysis by calpain (Chen and Stracher
1989). Calcineurin has been shown to dephosphorylate the C-terminal region of
filamin (García et al. 2006) and FLNa seems to associate with protein tyrosine
phosphatase PTP-PEST (Playford et al. 2006). Apart from proteolysis and
phosphorylation not much is known about filamin post-translational modifications
and how these contribute to FLN structure and function. Recently FLNa has been
detected to undergo serotonylation by transglutaminase in arterial vascular smooth
muscle (Watts et al. 2009).
3.2.1. Actin-binding Domain
ABDs of FLNs are closely related to the ABDs of spectrin, -actinin, dystrophin,
utrophin, plectin and fimbrin (Gorlin et al. 1990; Clark et al. 2009; Sawyer et al.
2009). FLN ABDs are 240–270 residues in length and contain two calponin
homology (CH) domains, CH1 and CH2. The CH domains of FLN isoforms share
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87% sequence identity and they are presumed to be very similar regarding structure
and actin-binding properties. FLNa and FLNc have a 20–30 residue N-terminal tail
not present in FLNb.
The first structure of FLN ABDs was the structure of FLNb ABD. Crystal
structures of FLNb ABD (PDB accession code 2WA5) and its W148R (PDB:
2WA6) and M202V (PDB: 2WA7) mutants were solved by Sawyer et al. (Sawyer
et al. 2009). The structure shows two CH domains with same overall fold tightly
bound together in closed conformation (Fig. 4). Both CH domains contain helices
A, C, D and E. There are additional short one-turn helices B and D’ in CH1 and
CH2, respectively. The flexible loop connecting the CH domains is closely located
with the C-terminus of the ABD and it is possible that it could interact with the first
Ig repeat. Substitution M202V is associated with atelosteogenesis I and III while
W148R is seen only in atelosteogenesis I (Krakow et al. 2004; Farrington-Rock et
al. 2006). The substitution mutants W148R and M202V closely retain the fold of
the native structure but lower the thermal stability of the domain. W148 is located at
helix A’ of CH2 and it points to the interior of CH2. M202 is located at CH2 helix
E’ and it resides in a rather hydrophobic environment. FLNb ABD mutations
W148R and M202V evoke increased F-actin binding affinities, which could explain
the gain-of-function phenotype of atelosteogenesis I and III.
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Fig. 4 The structure of FLNb ABD (Sawyer et al. 2009). (A) Native FLNb ABD.
CH1 and CH2 domains are colored in blue and red, respectively, and the helices are
marked with their letter codes. Yellow areas correspond to the known actin-binding
sequences (ABS). Panels (B) and (C) show the superpositions of the native FLNb
ABD structure (blue) and the structures of W148R (orange) and M202V (green)
mutants, respectively. Mutated residue is indicated with stick representation.
Superpositions show that the structures of the mutated forms closely match with the
native structure. Reprinted with permission from (Sawyer et al. 2009). © 2009
Elsevier.
The structure of FLNa ABD has recently been solved by two independent
research groups (Clark et al. 2009; Ruskamo and Ylänne 2009). FLNa and FLNb
ABDs  are  structurally  very  similar  (Fig.  5).  N-terminal  tail  of  FLNa  ABD  not
present in FLNb is not observed in the electron density map and is thus presumably
disordered. Clark et al. have  also  determined  the  structure  of  FLNa  ABD  with
E254K mutation (Clark et al. 2009). This mutation, which is manifested in humans
as otopalatodigital syndrome type 2 (OPD2), is located at the CH2 domain of FLNa
ABD (Robertson et al. 2003). Like the FLNb ABD mutants studied by Sawyer et
al., FLNa ABD E254K mutant closely retains the fold of wild-type domain (Fig. 5)
but the structure has reduced stability. The phenotype of OPD2 is thought to arise
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from a gain-of-function mechanism and consistency with this, E254K mutation was
shown to enhance the actin-binding affinity of FLNa ABD.
Fig. 5 The structure of FLNa ABD. Structures of wild-type FLNa ABD (blue) and
its E254K mutant (cyan) (Clark et al. 2009) and the structure of FLNb ABD
(magenta) (Sawyer et al. 2009) were superimposed to visualize their structural
differences. The mutated residue of FLNa ABD (E254) forming a salt bridge with
K169 and the structurally equivalent residues of FLNb ABD are represented with
stick models. Compared to the perspective shown in Fig. 4, the structures have been
rotated 180° along the vertical axis. The overall fold of FLNa and FLNb ABDs is
almost identical. FLNa ABD E254K mutant closely retains the structure of the
native domain. PDB accession codes: FLNa ABD, 3HOP; FLNa ABD E254K,
3HOC; FLNb ABD, 2WA5.
3.2.2. Rod Domain: Immunoglobulin-like Domains
Filamins contain two elongated rod domains which are composed of 24 consecutive
immunoglobulin-like domains. The seven  sheet fold of the rod repeats (Fig. 6)
was first suggested by Gorlin et al. based on sequence comparisons (Gorlin et al.
1990). FLN Ig repeats have an average length of ~96 residues. It was also pointed
out that the C-terminal repeat is responsible for filamin dimerization. The first
Filamins
19
structural evidence to support the immunoglobulin-like fold of the FLN rod repeats
was obtained from structure determination of highly homologous Dictyostelium
filamin (ABP-120) rod domain segment 4 (Fucini et al. 1997). This structure was
determined by solution state NMR spectroscopy and it was the first example of Ig
fold found in ABP. The structure was closest to the topological subtype C1 of the
immunoglobulin superfamily (Fig. 2) which was previously seen only in cell-
surface proteins. The sequence of ABP-120 rod repeat 4 does not show close
homology to any other proteins with Ig fold. As IgFLN sequence resembles the
sequence of ABP-120 repeats it was suggested that IgFLN repeats also potentially
have the same fold.
Fig. 6 General structure and topology of filamin-type Ig domains presented using
IgFLNa23 (PDB code: 2K3T) as an example. Letter codes used for the  strands are
indicated.
To date there are several structures of human IgFLNs in the PDB database
(see Table 4). Most of them are isolated single-domain structures. IgFLN fold
belongs to the E-set superfamily of the immunoglobulin-like folds (Murzin et al.
1995) resembling the I-topology of immunoglobulin superfamily (Fig. 2). The
majority of the structures are solved using NMR spectroscopy as part of the
structural genomics initiative and they have not been published as part of any
research article. At the moment there are no structures of IgFLNs 1–8 in the PDB
database. For some domains there are structures available for several isoforms.
Structural comparison shows that the highly homologous isoforms are also
structurally very similar (see Fig. 26 for an example). Complex structures of
IgFLNa17 and 21 with their binding partners reveal general interaction mechanism
of IgFLNs (see Chapter 3.3.2).
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code Reference (if available)




Clark et al. 2009
A: ABD X-ray 2WFN Ruskamo and Ylänne 2009




Sawyer et al. 2009
B: ABD X-ray 3FER
B: 9 NMR 2DI9
B: 10 NMR 2DIA
B: 11 NMR 2DIB
B: 12 NMR 2DIC
B: 13 NMR 2DJ4
B:14 NMR 2E9J
C: 14 NMR 2D7M
B: 15 NMR 2DMB
A: 16–17 NMR: Domain association of 16–17 2K7P IV
B: 16 NMR 2EE9
C: 16 NMR 2D7N
A: 17 X-ray: Complex with GPIb  peptide 2BP3 I
A: 17 NMR 2AAV I
B: 17 NMR 2EEA
C: 17 NMR 2D7O
A: 18–19 NMR: Domain association of 18–19 2K7Q IV
B: 18 NMR 2DMC
B: 19 NMR 2DI8
A: 19–21 X-ray: Domain association of 20–21 2J3S Lad et al. 2007
B: 20 NMR 2DLG,2E9I
A: 21 X-ray: Complex with integrin 7 peptide 2BRQ Kiema et al. 2006
A: 21 X-ray: Complex with integrin 2 peptide 2JF1 Takala et al. 2008
A: 21 X-ray: Complex with migfilin peptide 2W0P Lad et al. 2008
A: 21 NMR: Complex with migfilin peptide 2K9U Ithychanda et al. 2009a
B: 21 NMR 2EE6
B: 22 NMR 2EEB
C: 22 NMR 2D7P
A: 23 NMR 2K3T II
B: 23 NMR 2EEC
C: 23 X-ray 2NQC Sjekloca et al. 2007
C: 23 NMR 2D7Q
A: 24 X-ray: Dimerization mechanism 3CNK Seo et al. 2009
B: 24 NMR 2EED
C: 24 X-ray: Dimerization mechanism 1V05 Pudas et al. 2005
A X-ray: Complex with CFTR peptide(Status 16.11.2009: unreleased) 3ISW
Filamins
21
Dimerization mechanism of FLNs was revealed in detail in the structure of
IgFLNc24 (Pudas et al. 2005). In the crystal structure of IgFLNc24, two domains
form a compact dimer using their CD faces (Fig. 7). The two domains are arranged
in antiparallel orientation. Identical domain interaction is seen in the crystal
structure of IgFLNa24 (Seo et al. 2009). Dimerization of Dictyostelium ABP-120
also takes place through antiparallel interaction of the C-terminal rod repeats and
involves edge-to-edge extension of the  sheets (McCoy et al. 1999). Atomic and
topological details of the dimerization mechanisms are however drastically
different. Dictyostelium ABP-120 dimerization takes place through strands B and
G. Topology of the Dictyostelium ABP-120 dimerization domain (domain 6) differs
from other domains: A strand is missing and there is an additional strand H.
Absence of strand A liberates BG face for dimerization. Topology of IgFLNa24 and
IgFLNc24 matches with other IgFLN domains and dimerization mechanism does
not necessitate major structural adjustment. While the dimerization of IgFLN24
produces two  sheets with same topology (A1B1E1D1C2F2G2A´2) the dimerization
of  ABP-120  domain  6  creates  two  very  different   sheets:  D1E1B1B2E2D2 and
H1G1F'1F1C1C2F2F'2G2H2. The preceding repeat 5 and the domain linker were also
seen to contribute to Dictyostelium ABP-120 dimerization. As IgFLN24
dimerization mode, as such, produces an antiparallel orientation of the filamin
monomers, but electron micrographs of filamins suggest a V-shaped structure, the
role of IgFLN23 and H2 in dimerization of human FLNs was studied by Sjekloca et
al. (Sjekloca et al. 2007). Their results show that IgFLNc23 does not have
preference for self-association and it interacts very little with domain 24. It seems
that H2 is forming a spacer or orientational guide between the two domains. They
concluded that IgFLNc24 is the sole determinant for FLN dimerization. Also other
cytoskeletal proteins have been found to use  sheet extension of the Ig modules for
dimerization, but their detailed interaction modes are different from filamins (Zou
et al. 2006; Pinotsis et al. 2008; Pinotsis et al. 2009). Isoform specificity of FLN
dimerization has also been studied but the results are ambiguous. Himmel et al.
have found that FLNb and FLNc are able to heterodimerize whereas FLNa only
forms homodimers (Himmel et al. 2003). In contrast, Sheen et al. have shown that
FLNa and FLNb are able to form heterodimers (Sheen et al. 2002). Their results,
however, also indicate that the FLNa–FLNb heterodimerization site might be
located at rod region 2, instead of domain 24. The experiments of Himmel et al.
were conducted with constructs containing IgFLN domains 22–24.
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Fig. 7 The dimerization mechanism of human filamins. Crystal structure of
IgFLNc24 reveals how the C-terminal IgFLN domains form an antiparallel dimer
using their CD faces. Reprinted with permission from (Pudas et al. 2005). © 2005
Elsevier.
It has been proposed that controlled unfolding and refolding of IgFLNs
could regulate filamin functions and have a role in mechanosensory signaling
(Johnson et al. 2007). Thus stability of IgFLN fold has been of interest. The
mechanical strength of Dictyostelium ABP-120 Ig domains has been studied both
with molecular dynamics simulations (Kolahi and Mofrad 2008) and with single-
molecule techniques (Schwaiger et al. 2004; Schwaiger et al. 2005). These studies
show that ABP-120 Ig domains unfold before the dimer dissociates and that domain
4 with a stable folding intermediate starts to unfold with smaller force than the other
domains. N-terminal unfolding of IgFLN domains under physiological forces was
observed in discrete molecular dynamic simulations (Kesner et al. 2009a) and it
was suggested that it could be a mechanism for exposure of cryptic binding sites,
removal of native binding sites, and modulation of the quaternary structure. The
mechanical strength of human filamins has also been studied with single-molecule
techniques (Furuike et al. 2001; Yamazaki et al. 2002). Thermal stability of IgFLN
domains has been studied using NMR spectroscopy (Jiang and Campbell 2008).
These studies have shown that IgFLNa21 is less stable than domains 17 and 19
even if it is structurally very similar to these domains.
There are only a few structures of multi-domain IgFLN constructs
available. Crystal structures of Dictyostelium ABP-120 multi-domain fragments
(McCoy et al. 1999; Popowicz et al. 2004) show that the linkers between the
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domains are relatively short and there are some inter-domain interactions between
the domains. Consecutive domains form a zigzag shaped modular construction.
Stability of the domain arrangement was studied with steered molecular dynamics
simulations (Kolahi and Mofrad 2008) and it was noted that the repeats lose their
staggered topology easily before any domain unfolding takes place. This means that
the inter-domain forces are relatively weak. At next stage the domain linkers extend
and lose their tertiary structure. It was speculated that despite the rigid conformation
and several domain–domain interactions seen in the crystal structure, under tension,
filamin rod domains become flexible, as seen in EM images (Hartwig et al. 1980).
Gorlin et al. noticed that filamin repeats 16, 18, 20, 22 and 24 have atypical
N-terminal sequences (Gorlin et al. 1990). Nowadays, structures are available on all
these domains. Domains 22 and 24 seem to have typical IgFLN folds, whereas
structures of IgFLN16, 18 and 20 seem to be deprived of strand A. It has now
become evident that these three domains are not structurally independent folding
units, but form higher-order structures with the following domain (Lad et al. 2007:
IV). First human filamin structure with multiple domains was the structure of
IgFLNa19–21 (Lad et al. 2007). IgFLNa19 and 21 have traditional IgFLN folds but
IgFLN20 is drastically different and the inter-domain organization is not linear (Fig.
8). The first  strand of IgFLNa20 is not a part of its own domain, but binds to the
CD face of domain 21 blocking the integrin binding site (Kiema et al. 2006).
Domain 20 is bound to the N-terminal end of domain 21 through a short  strand
interaction between IgFLNa20 strand G and IgFLNa21 BC loop. It is worth noting
that FLN splice variants lacking the inhibitory strand A of domain 20, and showing
enhanced integrin binding, have been previously reported (van der Flier et al.
2002). This implies that the domain interaction could have an auto-inhibitory role.
Also, structures of IgFLNa16–17 and 18–19 double-domains are now available and
these provide yet more new domain interaction modes of IgFLN domains (see
Chapter 7.2 for further details) (IV). Crystallization of IgFLNa14–16, which
contains the H1 region, has also been reported (Aguda et al. 2007), but the structure
is not yet available. Pentikäinen and Ylänne have studied the stability of the
IgFLNa domain pairs 18–19 and 20–21 with steered molecular dynamics
simulations (Pentikäinen and Ylänne 2009). They noticed that mechanical force
applied to filamin can expose cryptic integrin binding sites by detaching the auto-
inhibitory strand A of the even-numbered domain from the CD face of the odd-
numbered domain, without unfolding the entire domains, and through this
mechanism filamins could act as a mechanotransducers. Johnson et al. have
screened for cytoskeletal proteins undergoing conformational changes due to
mechanical cell stress and their results suggested that filamins could be involved in
mechanosensory signaling (Johnson et al. 2007).
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Fig. 8 The structure of IgFLNa19–21 (Lad et al. 2007). IgFLNa domains have
been numbered and colored to emphasize the peculiar nonlinear domain
organization. The locations of N- and C-termini are also indicated.
The first electron micrographs of filamins showed that the average length of
filamin monomer is 80 nm (Hartwig et al. 1980). This is substantially less than
would be expected for an almost linear array of 24 independent IgFLN domains
whose approximate length is 4–5 nm. Dimensions of several filamin constructs
have been studied with electron microscopy (Nakamura et al. 2007). Overall length
of rod 2 (IgFLNa16–23) is considerably smaller than for constructs of same size
from rod 1 (IgFLNa1–8 and 8–15) (Fig. 9). The average spacing of Dictyostelium
ABP-120 Ig repeats in the three-domain construct having the zigzag arrangement
was 3.7 nm (Popowicz et al. 2004). This would make 30 nm for eight consecutive
repeats which is in pretty good agreement with IgFLNa1–18 and 8–15 construct.
Average repeat spacing is however only 2.4 nm for FLN rod 2 (Nakamura et al.
2007). This clearly states that several domains in FLN rod 2 must exhibit more
compact domain packing.
Fig. 9 Electron micrographs of rotary shadowed FLNa and truncated constructs
fused to a His(hexahistidine)-tag. The rod 2 has a more globular and compact
appearance. Reprinted and adapted with permission from (Nakamura et al. 2007). ©
2007 Nakamura et al.
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3.3. Interactions of Filamins
Filamins were first identified as actin-binding proteins but have since been shown
to host a range of other interaction partners—they have even been reproached for
being promiscuous (Popowicz et al. 2006). Interaction partners of filamins include
membrane receptors and channels, enzymes, signaling intermediates and
transcription factors (Stossel et al. 2001; Feng and Walsh 2004; Zhou et al. 2007a).
Filamins seem to act as versatile mediators between the cytoskeleton and the
proteins of the cell membrane. They anchor various transmembrane proteins, e.g.,
cell adhesion molecules, to the cytoskeleton and thereby localize the membrane
proteins to correct areas at the cell surface and mediate forces and signals from
extracellular matrix to cytoskeleton. They also function as signaling scaffolds by
coordinating several intracellular signaling intermediates. Different filamin related
diseases are proposed to highlight different filamin interactions (Feng and Walsh
2004). Mutations localized at the binding areas of certain proteins disrupt this
specific interaction, probably leaving other functions intact.
3.3.1. Interaction with Actin
Soon after identification of filamin, the actin-binding properties of the protein were
characterized in more detail. Wand and Singer found that filamin collects actin
filaments into thick bundles or into networks and they stated that in this way,
filamins could regulate the ultrastructural state of F-actin filaments in a variety of
dynamic cellular processes (Wang and Singer 1977). A decade later Hartwig and
Shevlin noticed in their studies of cytoskeleton of lung macrophages that actin-
binding protein, i.e., filamin, is found at high-angle actin filament intersections and
at points where filaments are in contact with the cell membrane (Hartwig and
Shevlin 1986).
Rheological properties of filamin–actin networks have been presented in
several papers. Electron micrographs of filamin–actin networks show high-angle
branching of the filaments (Fig. 10) and branch distances are inversely proportional
to the filamin concentration (Hartwig et al. 1980; Niederman et al. 1983). Filamin
induces gelation of actin (Brotschi et al. 1978; Hartwig and Stossel 1981). Filamin
dimerization is a prerequisite for efficient actin cross-linking, -bundling and -
gelation. Hinge 1 seems to be essential for visco-elasticity of the filamin–actin
networks (Goldmann et al. 1997; Gardel et al. 2006). The mechanical strength of
filamin–actin interaction has been measured using single molecule techniques
(Yamazaki  et  el.  2002;  Ferrer et al. 2008). It was noted that the IgFLN domains
unfold with less force than that needed to break the interaction with actin, and
unfolding of the domains was seen to be reversible. Several studies exist where
properties of filamin induced actin networks have been compared with networks
generated by other ABPs. Filamin cross-linked F-actin networks are more resilient,
stiffer, more solid-like and less dynamic than the actin networks generated by -
actinin and fascin (Tseng et al. 2004). Nakamura et al. have studied the differences
in mechanical properties of filamin-crosslinked and Arp2/3-branched actin
filaments (Nakamura et al. 2002). Filamin-cross-linked actin network is flexible,
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orthogonal, fairly resistant meshwork adapting to morphological changes and thus
enabling slow cell migration (Flanagan et al. 2001).
Fig. 10 Electron microscopic images of filamin–actin networks. (A) Actin-to-
filamin concentration ratio affects morphology of actin networks: 10 m actin in the
presence of gelsolin (1:2000) without filamin (left); and with 300:1 (middle) and
20:1 (right) actin-to-filamin ratios. Reprinted and adapted with permission from
(Goldmann et al. 1997). © 1997 Federation of European Biochemical Societies. (B)
Also ABD deficient FLNa constructs are able to align F-actin into bundles. Another
actin-binding site is located at IgFLN domains 8–15. Reprinted and adapted with
permission from (Nakamura et al. 2007). © 2007 Nakamura et al.
The actin-binding site of filamin A was characterized in 1990s (Lebart et al.
1994). Based on sequence alignment with other ABPs it was known already that the
actin-binding activity is located at the N-terminal part of the protein, i.e., at the
ABD. Lebart et al. mapped the actin-binding activity of FLNa to hydrophobic
stretch of residues 121–147 (corresponding to actin-binding sequence 2 (ABS2) in
Fig. 4), but they also noted that other, presumably hydrophilic, regions participate
in the interaction making it sensitive to increasing salt concentrations (Lebart et al.
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1994). Filamin–actin interaction was characterized also from the actin’s point of
view (Méjean et al. 1992). Filamin binding site was located at actin residues 105–
120 and 360–372 at actin subdomain 1 (Fig. 11). Recently new light was shed on
the filamin–actin interaction by Nakamura et al. (Nakamura et al. 2007). They
showed that ABD of filamin is essential for actin gelation but it is not the only
actin-binding region of filamin. Substantial actin-organizing activity was seen also
in IgFLN domains 9–15 (Fig. 10).
Fig. 11 The filamin binding site in actin monomer (Otterbein et al. 2001; Méjean et
al. 1992). G-actin subdomains S1, S2, S3 and S4 have been indicated with different
colors. Filamin-binding residues (105–120 and 360–372) are colored in red.
Structural characterization of filamin–actin interaction became possible
after the structure of the FLNb ABD was solved (Sawyer et al. 2009). Three actin-
binding sequences (ABS) have been identified in ABPs with double CH domain
ABD. ABS1 and ABS2 are located near the N- and C-termini of the CH1 domain,
respectively, while the ABS3 is at the CH2 domain (see Fig. 4). Both CH domains
contribute to actin-binding so the entire ABD is needed for fully functional filamin–
actin interaction. It should be noted that the three ABSs do not form a continuous
surface, but conformational change probably aligns the actin-binding regions during
binding. Lehman et al. have reviewed the conformation studies of CH domain-
containing ABDs of several proteins (Lehman et al. 2004). FLNb ABD binds to F-
actin at 1:1 molar ratio with dissociation constant Kd of  7.0  M  (Sawyer et al.
2009). The patient mutations W148R and M202V seemed to enhance the actin
binding affinity of FLNb ABD. These mutations lead to autosomal dominant gain-
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of-function FLNb disorders characterized by vertebral abnormalities, bone
dysplasia and joint dislocations (Farrington-Rock et al. 2006). Enhanced actin-
binding activity of FLNb explains the gain-of-function phenotype but it remains
unclear how these rather remote point mutants closely retaining the fold of the
native ABD can alter the affinity. FLNa ABD mutation E254K, which located at the
vicinity of ABS1 and ABS3, has been shown to enhance actin-binding affinity of
FLNa (Clark et al. 2009).
Interaction of filamin with actin can be regulated through several
mechanisms. Proteolysis of filamins at hinge regions separates the dimerisation
from actin-binding activity which means that filamins lose their ability to cross-link
actin. Filamin–actin-filament cross-linking has been shown to be modulated by
tyrosine kinase p56lck (Goldmann 2001; Pal Sharma and Goldmann 2004). Ca2+-
calmodulin has been shown to regulate the filamin–actin interaction through
binding to the ABD of FLNa and thus dissociating the filamin from actin
(Nakamura et al. 2005). Ca2+-calmodulin seems to be unable to bind to the ABD of
free filamin which means that it could act as a switch to release the filamin from
actin filaments. Filamin activity can also be localized to certain cytoskeletal sites
through the ABD. Recently, it has been shown that differences in the ABDs of
filamin and -actinin direct these proteins to different cellular locations
(Washington and Knecht 2008).
3.3.2. Interactions of the Rod Domains
IgFLN domains, especially the domains 16–24, are actively interacting modules in
filamins (Stossel et al. 2001; van der Flier and Sonnenberg 2001b; Feng and Walsh
2004; Popowicz et al. 2006; Zhou et al. 2007a). Table 5 summarizes the interaction
partners of human filamins. It should be noted that some of the partners could be
assigned to several categories, but the most itemized and descriptive of the suitable
categories was chosen. The number of interaction partners is extensive. One has to
keep in mind that there might also be some false positives, and the interaction site
can be mapped to a false location. The majority of the interaction studies have used
the yeast two-hybrid system (Fields and Song 1989) for identification of the
interaction region and, unfortunately, domain boundaries are not always considered
in these studies. Clipping of domains in parts might produce hydrophobic patches
that can interact non-specifically. As the number of interactions is vast, the entirety
will not be covered here in detail. The rest of this chapter will be devoted to the
details of the interactions that are studied in the experimental part of this thesis.




Table 5 Molecules that have been shown to physically interact with the rod
domains of human filamins.
Interaction partner FLN isoform:interacting repeats References
Transcription regulators
Androgen receptor A/C: 16–19
Ozanne et al. 2000;
Loy et al. 2003;
Wang et al. 2007
FOXC1 A: 4–9 & 16–21 Berry et al. 2005
PEBP2/CBF A: hinge2–24 Yoshida et al. 2005
p73 A: 20–24 Kim et al. 2007b
Smad2, 3 & 5 (TGF-  signaling) A/B: 20–23 Sasaki et al. 2001;Zheng et al. 2007
BRCA2 tumor suppressor A: 21–24 Yuan and Shen 2001
Cell adhesion and motility
FAP52 A: 13–16 Nikki et al. 2002
FILIP (Filamin A-interacting protein) A: 15–18
Nagano et al. 2002;
Nagano et al. 2004;
Sato and Nagano 2005
GPIb A/B: 17
Fox 1985;
Okita et al. 1985;
Meyer et al. 1997;
Takafuta et al. 1998;
Xu et al. 1998;
Williamson et al. 2002;
Feng et al. 2003;
Cranmer et al. 2005;
Feng et al. 2005;
I
Integrin 1, 2, 3, 7 A/B/C: 20–24
Pal Sharma et al. 1995;
Loo et al. 1998;
Pfaff et al. 1998;
Calderwood et al. 2001;
van der Flier et al. 2002;
Tadokoro et al. 2003;
Travis et al. 2004;
Gontier et al. 2005;
Kiema et al. 2006;
Kim et al. 2008;
Takala et al. 2008
Migfilin (filamin-binding LIM protein-1, FBLP-1) A: 21
Takafuta et al. 2003;
Tu et al. 2003;
Lad et al. 2008;
Ithychanda et al. 2009a
Endothelial-specific molecule-2 (ECSM2) A: 15–16 & 19–21 Armstrong et al. 2008
IKAP (I B-kinase-associated protein) A Johansen et al. 2008
CEACAM1/CD66a antigen A: 23–24 Klaile et al. 2005
Vimentin A Kim et al. 2009




Interaction partner FLN isoform:interacting repeats References
Myofibril assembly
Calsarcin-3 C: 20–24 Frey and Olson 2002
Myotilin C: 19–21 van der Ven et al. 2000;Gontier et al. 2005
FATZ-1
(Calsarcin-2/Myozenin-1) A/B/C: 19–24
Faulkner et al. 2000;
Takada et al. 2001;
Gontier et al. 2005
N-RAP C: 20–24 Lu et al. 2003
KY protein C: 20–22 Beatham et al. 2004
Titin A/C Labeit et al. 2006
Xin (cardiomyopathy associated protein) C: 20 van der Ven et al. 2006
Cbl-associated protein (CAP) C: 2 Zhang et al. 2007
- & -sarcoglycans C: 20–24 Thompson et al. 2000
G-protein coupled receptors
Dopamine receptors D2 & D3 A: 19
Li et al. 2000;
Lin et al. 2001;
Lin et al. 2002;
Kim et al. 2005b;
Cho et al. 2007
mGluR A: 21–22 Enz 2002
 opioid receptor A: hinge2–24
Onoprishvili et al. 2003;
Onoprishvili and Simon 2007;
Onoprishvili et al. 2008
Extracellular calcium-sensing receptor A: 14–16 Awata et al. 2001;Hjälm et al. 2001
Calcitonin receptor A: 20–21 Seck et al. 2003
P2Y2 nucleotide receptor A Yu et al. 2008
Ion channels
CFTR (Cystic fibrosis transmembrane conductance
regulator) A Thelin et al. 2007
Kv4.2 potassium channel A/C: 20–24 Petrecca et al. 2000
Large-conductance Ca2+-activated K+ (BKCa)
channels A: 14–19 Kim et al. 2007a
Kir2.1 (Inwardly rectifying potassium channel) A: 23–24 Sampson et al. 2003
HCN1 (pacemaker channel) A: 23–24 Gravante et al. 2004
Acetylcholine receptor (AChR) A Shadiack and Nitkin 1991
Polycystin TRPP2 A Sharif-Naeini et al. 2009
Other transmembrane proteins
Caveolin-1 A/B: 22–24 Stahlhut and van Deurs 2000
Presenilins (causative factors in early-onset familial




Interaction partner FLN isoform:interacting repeats References
Intracellular signaling intermediates
FilGAP (Rac GTPase-activating protein) A: 23
Ohta et al. 2006;
II;
Shifrin et al. 2009
Ras-related small GTPases Rac, Rho, Cdc42, & RalA A: hinge2–24 Ohta et al. 1999
RasGAP (GTPase-activating protein) C: 15–17 Lypowy et al. 2005
Trio (Rac1- and RhoG-specific guanidine exchange
factor) A: 23–24 Bellanger et al. 2000
-arrestin A: 22 Kim et al. 2005b;Scott et al. 2006
LL5  (Phosphatidylinositol (3,4,5)-trisphosphate
sensor) C: 20–24
Paranavitane et al. 2003;
Paranavitane et al. 2007
Phosphorylation pathways
RSK (Ribosomal S6 kinase, filamin phosphorylation) A: Ser2152 Woo et al. 2004
Insulin receptor A: 22–24 He et al. 2003
ROCK/Rho-associated protein kinase A: 24 Ueda et al. 2003
SHIP-2 (inositol polyphosphate 5-phosphatase) A/B/C: 22–24 Dyson et al. 2001
SphK1  (Sphingosine kinase 1) A: 22–24 Maceyka et al. 2008
SEK-1 (Stress-activated protein kinase activator) A: 21–23 Marti et al. 1997
PTP-PEST (protein-tyrosine phosphatase) A Playford et al. 2006
Calcineurin (filamin dephosphorylation) A: Ser2152 García et al. 2006
Pak1 (filamin phosphorylation) A: Ser2152 Vadlamudi et al. 2002
Cyclin B1/Cdk1 (filamin phosphorylation) A: Ser1436 Cukier et al. 2007
p56lck (Tyr kinase, filamin phosphorylation) A Pal Sharma and Goldmann 2004
PKA (filamin phosphorylation) A: Ser2152 Jay et al. 2000; Jay et al. 2004
PKB-  (filamin phosphorylation) C: Ser2213 Murray et al. 2004
PKC-  (filamin phosphorylation) A & C: 1–4 & 23–24 Tigges et al. 2003
PKC- A Hayashi and Altman 2006
CaM kinase II  (Ca2+/calmodulin-dependent
protein kinase II, filamin phosphorylation) Ohta and Hartwig 1995
cAMP-dependent protein kinase (filamin
phosphorylation) Chen and Stracher 1989
Inflammatory and immune signaling
Tc-mip (truncated c-maf inducing protein) A: 18–19 Grimbert et al. 2004
CD4, HIV receptor A: 10 Jiménez-Baranda et al. 2007
Fc RI  (class I IgG receptor) A Ohta et al. 1991;Beekman et al. 2008
14-3-3 Nurmi et al. 2006
CD28 A: 10–12 Tavano et al. 2006
TRAF2 (Tumor necrosis factor (TNF) receptor-
associated factor 2) A: 15–19 Leonardi et al. 2000
ICAM-1 (intracellular adhesion molecule-1) (A)/B: 19–20 Kanters et al. 2008
Rac1, MEKK1, MKK4, & JNK1 (Janus Tyr-kinase
signaling pathway) B: 20–24 Jeon et al. 2008




Interaction partner FLN isoform:interacting repeats References
Proteases and peptidases
Epithin (membrane type-serine protease 1,
matriptase) A/B: 14–24 Kim et al. 2005a
Furin (protease of the trans-Golgi network) A: 13–14 Liu et al. 1997
PMSA (Prostate-specific membrane antigen) A: 23–24 Anilkumar et al. 2003
Calpain 1 & 3 (filamin proteolysis) A: cleavage at hinge1C: cleavage at hinge2
Gorlin et al. 1990;
Guyon et al. 2003;
Raynaud et al. 2006
Granzyme B (filamin proteolysis) and caspase A Browne et al. 2000
Miscellaneous
Pdlim2 (PDZ and LIM domain-containing protein) A Torrado et al. 2004
Hepatitis B virus core protein B: 23–24 Huang et al. 2000
Decorin (extracellular protein) A: 22–24 Yoshida et al. 2002
cvHsp (Heat shock protein) A: 23–24 Krief et al. 1999
Nephrocystin (mutated in juvenile nephronophthisis) A/B: 15–16 Donaldson et al. 2002
Pro-PrP (cellular pro-prion protein) A: 24 Li et al. 2009
Naloxone A: 24 Wang et al. 2008;Wang and Burns 2009
[14C]-carboplatin Shen et al. 2004
Platelet Activation: Glycoprotein Ib
Glycoprotein Ib  (GPIb ) was the first FLN binding partner identified after actin
(Fox et al. 1985; Okita et al. 1985). GPIb  is an essential factor of the mechanism
of platelet adhesion and activation leading eventually to blood clotting (Andrews et
al. 1997; Du 2007). GPIb  is a part of glycoprotein Ib–IX–V (GPIb–IX–V)
complex (Fig. 12). GPIb–IX–V platelet adhesion complex is a receptor for von
Willebrand factor (VWF), a sub-endothelial matrix-bound multimeric adhesive
glycoprotein. The absence or mutations of VWF lead to von Willebrand disease
(Mannucci 2004), whereas Bernard–Soulier Syndrome is a disease caused by
defects in the GPIb–V–IX complex (Lopez et al. 1998). A symptom of these
diseases is either bleeding or increased thrombosis, presumably depending on the
type of mutation (loss-of-function or gain-of-function). Inhibition of platelet GPIb–
IX–V complex could potentially be used as a target for antithrombotic agents and
several inhibitors, e.g., monoclonal antibodies, peptides and snake venom proteins,
are known (Vanhoorelbeke et al. 2007).
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Fig. 12 Schematic diagram of platelet membrane GPIb–XI–V complex. Binding
site of FLNa (actin-binding protein) on GPIb  is indicated. Reprinted with
permission from (Andrews et al. 1997). © 1997 Elsevier.
The role of FLNa is to link the glycoproteins of the platelet plasma
membrane to the cytoskeleton. FLNa binding to the cytoplasmic tail of GPIb  was
noted to regulate proaggregatory tyrosine kinase signaling of platelets (Feng et al.
2003). GPIb  binds to FLNa already within the endoplasmic reticulum (ER) and
FLNa directs the post-ER trafficking of GPIb  and cell surface expression of GPIb–
IX–V (Feng et al. 2005). FLNa was the isoform first identified to bind GPIb , but
FLNb was also later identified as GPIb  binding protein (Takafuta et al. 1998; Xu
et al. 1998). The interaction site for GPIb  was mapped to the IgFLNa domains 17–
19 (Meyer et al. 1997). Residues 557–575 are the binding site for filamin in GPIb
(Williamson et al. 2002; Feng et al. 2003) and residues F568 and W570 were found
to be especially important (Cranmer et al. 2005). Structure of GPIb –IgFLNa17
complex has been solved using X-ray crystallography (I). Complex structure shows
that GPIb  residues 560–573 bind as an additional  strand next to IgFLNa17
strand C (Fig. 13). GPIb  residues F563, L567, F568, L569, V571 and W570 make
remarkable hydrophobic contacts with the CD face of IgFLNa17. Further
identification of the interaction is described in Chapter 7.1.1.
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Fig. 13 The  structural  basis  of  the  interaction  of  FLNa  and  GPIb  (I). GPIb
residues 560–573 bind as an additional  strand next to IgFLNa17 strand C
(residues 1896–1904). Binding is mainly determined by hydrophobic interactions.
Reprinted and adapted with permission from (I). © 2006 The American Society of
Hematology.
Cell Adhesion Receptors: Integrins
Integrins are heterodimeric transmembrane cell adhesion molecules that
link the extracellular matrix to the cytoskeleton (van der Flier and Sonnenberg
2001a; Hynes 2002). Integrins can organize cytoskeleton and control intracellular
signaling pathways. There are 18  and 8  integrin subunits in the human genome
and by forming  dimers they generate 24 versatile dimeric receptors for
extracellular matrix ligands or counter-receptors in other cells. Integrins have an
important role in cell adhesion in focal adhesions (Lo 2006) and in cell migration
(Ridley et al. 2003). Several cytoplasmic proteins interact with the cytoplasmic
domains of integrins and many of these also bind actin (Wiesner et al. 2005).
Filamins, in concert with vimentin and PKC , have been proposed to regulate
integrin trafficking and possibly activation (Kim et al. 2009).
Filamins were identified as integrin binding proteins a decade ago.
Cytoplasmic domain of integrins 1, 2 and 7 were shown to interact with the C-
terminal part of FLNa (Pal Sharma et al. 1995; Loo et al. 1998; Pfaff et al. 1998).
Later, integrin 3 tails were also identified as FLN binding partners (Tadokoro et al.
2003) and FLNc was shown to have binding activity with the 1A integrin subunit
(Gontier et al. 2005). Filamin binding was noted to restrict integrin-dependent cell
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migration by inhibiting transient membrane protrusion and cell polarization
(Calderwood at al. 2001) and the effect was more pronounced with integrin 7 than
with 1A or 1D. It was noted that affinity of FLNa for 7 was higher than for 1A
and FLNa repeats 19–24 mediate the interaction. FLNa and FLNb splice variants
which lack a 41 residue sequence between IgFLN domains 19 and 20 were noted to
bind integrin 7 tails more strongly than the wild type isoforms (van der Flier et al.
2002; Travis et al. 2004) and it was speculated that alternative mRNA splicing
could control the cellular localization of filamins and their interaction with
integrins. Travis et al. also tested whether filamin phosphorylation had an effect on
integrin binding but they concluded that phosphorylation of S2131 or S2152 does
not play a role in regulating the interaction of filamin with the 7 integrin tail
(Travis et al. 2004). Recently, filamin A has been shown to regulate cell spreading
and survival via 1 integrins (Kim et al. 2008).
Calderwood et al. characterized the FLN binding site of integrin tails in
detail (Calderwood at al. 2001). Residues 781–786 of the 7 tail are necessary for
high-affinity FLNa binding and I782 and I786 seem to be especially important. It
has been shown that the main integrin binding domain of FLNa is repeat 21 but
repeat 19 also has some affinity for integrin 7 (Kiema et al. 2006). Kiema et al.
have solved the IgFLNa21–integrin 7 complex structure using X-ray
crystallography (Fig. 14). Residues 776–788 of the integrin 7 tail bind to the CD
face of IgFLNa21. The interaction resembles the FLN–GPIb  interaction as integrin
7 peptide also binds as an extra  strand to the strand C of IgFLNa21. Integrin 7
residues Y778, I782 and I786 make hydrophobic contacts with the residues of
IgFLNa21. T784 is also buried in the interaction interface and it was proven that
phosphothreonine mimicking modification T284E abolished the interaction, which
implies that phosphorylation of the 7 tail may regulate integrin–filamin
interactions. Later, the mechanism behind the higher affinity of FLN splice variants
towards integrins was revealed in the structure of IgFLNa19–21 (see Fig. 8) (Lad et
al. 2007). Strand A of IgFLNa20 is bound to strand C of IgFLNa21 and it blocks
the integrin binding site seen in the FLNa21–integrin 7 complex (see Fig. 8).
Filamin splice variants lack the N-terminal residues of IgFLNa20 and thus the
integrin binding site is not blocked (van der Flier et al. 2002; Travis et al. 2004).
Also another filamin–integrin complex structure is available: IgFLNa21–integrin 2
complex (Fig. 14) (Takala et al. 2008). The structure of the complex is pretty much
the same as in the case of 7 tail, but it was shown that phosphorylation of 2
integrin tail on T758 acts as a molecular switch to inhibit filamin affinity and
promote 14-3-3 protein binding to this integrin. The regulation mechanisms of
adaptor binding to  integrin cytoplasmic tails have recently been reviewed by
Legate and Fässler (Legate and Fässler 2009).
All filamin interactions that have been structurally characterized so far—
filamin dimerization; FLNa–GPIb ; FLNa–integrin 2; and FLNa–integrin 2
complexes—show the same interaction mode: the interaction partner binds as an
additional  strand to the CD face of an IgFLN domain and extends the A’GFC 
sheet (Pudas et al. 2005; Kiema et al. 2006; I; Takala et al. 2008). It has been
speculated whether or not this is a general filamin interaction mode. Different
interactions would localize to different Ig modules based on the sequence of the
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binding partner and the structural details of CD faces of the domains. This way the
different interactions could be independently regulated.
Fig. 14 IgFLNa21–integrin complexes. Cytoplasmic tails of integrin 7 (A–B) and
2  (C)  bind  as  an  additional   strand  to  IgFLNa21  strand  C  (Kiema et al. 2006;
Takala et al. 2008). Panel D shows a superposition of the two integrin tails on the
CD face of IgFLNa21. Blue, integrin 7; orange, integrin 2. A–B: reprinted and
adapted with permission from (Kiema et al. 2006). © 2006 Elsevier. C–D: reprinted





Filamins host a range of intracellular signaling intermediates (see Table 5). One of
these is the recently identified GTPase-activating protein FilGAP that controls actin
remodeling (Ohta et al. 2006). FilGAP is regulated by Rho-associated kinase
ROCK and its GAP-function targets intrinsic GTPase activity of Rac. ROCK
regulates FilGAP activation by phosphorylation and FilGAP controls cell polarity
and movement downstream of ROCK (Fig. 14). FilGAP acts as a suppressor of
Rac-mediated cell polarization. In response to cell stimulation, FLNa targets
FilGAP to specific cellular sites, especially to lamellae, where FilGAP suppresses
lamellae extension. FilGAP suppresses leading edge protrusion and promotes cell
retraction, thereby contributing to the regulation of cell polarity. Both these
processes involve actin remodeling. FLNa, a potential coordinator of actin
remodeling, interacts with several signaling molecules, e.g.,  Rho GTPases (Ridley
2006), shown to participate in actin network dynamics. FLNa seems to be a general
partnering site for the Rho GTPases Rac, Rho, Cdc42, and RalA (Ohta et al. 1999)
and colocalizes with Rho guanine nucleotide exchange factor (GEF) Lbc (Pi et al.
2002). FLNa also interacts with the Rac- and RhoG-specific GEF Trio (Bellanger et
al. 2000) and kinases ROCK (Ueda et al. 2003) and Pak1 (Vadlamudi et al. 2002).
FLNa seems to act as an interaction platform for all these components of the actin
remodeling pathway. FLNa co-localizes FilGAP with the upstream factors that can
activate and inactivate it and with Rac that can further regulate localized actin
assembly. FLNa could participate in temporal–spatial regulation of signals that
promote cell polarity.
FilGAP contains 748 residues and has MW of 84 kDa (Ohta et al. 2006).
Residues 552–748 were identified as the FLNa-binding domain. By sequence
homology, FilGAP also contains an N-terminal pleckstrin homology (PH) domain
(residues 19–125), RhoGAP, and coiled-coil (CC) domains (Fig. 16). FLNa repeats
23–24 exhibit strong FilGAP affinity but repeat 23 alone also has some activity.
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Fig. 15 The role of FilGAP and other FLNa-binding partners in determining cell
polarity. Blue shading represents the FLNa platform that collects up the signaling
intermediates. Blue and purple rectangles stand for activated and inactivated forms,
respectively. Reprinted with permission from (Ohta et al. 2006). © 2006 Nature
Publishing Group.
Fig. 16 Schematic structure of FilGAP: PH, pleckstrin homology domain; GAP,
GTPase activating domain; CC, coiled-coil domain. FLNa binding site is located at




Filamin–FilGAP interaction was further characterized by Nakamura et al.
(II). It was observed that FilGAP does not bind FLNa homologs FLNb or FLNc,
even if they are sequentially very similar. It was also noted that FLNa mutations
found in PVNH and FMD patients disrupt the folding of IgFLNa23 and abolish
FilGAP binding. The filamin interaction site in FilGAP was further refined to the
last 32 residues (717–748) of FilGAP. FilGAP was noted to dimerize using the
coiled-coil domain. Affinity of isolated IgFLNa23 for monomeric FilGAP was very
low, which demonstrates that both FLNa and FilGAP dimerization is required for
fully efficient interaction. It was speculated that dimerization of the interaction
partners defines their geometric arrangements and valences increasing avidity of the
FLNa–FilGAP complex. Rac inactivation by FilGAP requires FLNa association.
FilGAP V734Y mutant was noted to be unable to bind FLNa and diffuse throughout
cell suppressing Rac-activity broadly, which indicates that binding of FilGAP to
FLNa is important for proper spatiotemporal control of FilGAP functions. Further
description of NMR characterization of FLNa–FilGAP interaction can be found in
Chapter 7.1.2 (II).
The role of FilGAP–FLNa interaction in mechanoprotection was studied by
Shiffrin et al. (Shifrin et al. 2009). Their results indicate that FLNa targets FilGAP
to sites of force transfer. Force-induced redistribution of FilGAP was noted to be
essential for suppression of Rac activity and lamellae formation in cells that are
challenged by tensile forces. Authors state that FilGAP plays a role in protecting
cells against force-induced apoptosis. The mechanoprotective role of filamins has
been previously proposed by Kainulainen et al. (Kainulainen et al. 2002)
G-protein Coupled Receptors: Dopamine Receptors
Several G-protein coupled receptors (GPCR), including dopamine receptors, have
been shown to interact with filamins (see Table 5). Dopaminergic signaling has a
central role in the pathophysiology of Parkinson’s disease and schizophrenia
(Civelli et al. 1993; Missale et al. 1998). The third cytoplasmic loop of D2-type
dopamine receptors has been indicated as the binding site for FLNa (Fig. 17) (Li et
al. 2000). There is a potential serine phosphorylation site (S238) close to the FLNa
binding site and interaction with FLNa can be regulated by PKC activation. FLNa
has  a  role  in  the  clustering  of  D2 receptors  at  the  cell  surface.  Association  of  D2
receptors with FLNa enhances their inhibitory coupling efficiency to adenylate
cyclase. The function of filamin could be the clustering of the components of the
dopaminergic signaling pathway close together.
Later it was shown that, in addition to D2 receptors, FLNa also interacts
with D3 subtypes but not with other subtypes (Lin et al. 2001). The binding site was
mapped to the IgFLNa domain 19. Residues 211–241 and 211–227 of D2L (long
form of D2 receptors)  and  D3 receptors, respectively, are responsible for the
interaction with FLNa. FLNa seemed to be required for proper cell surface targeting
and stabilization of the dopamine receptors (Lin et al. 2002). D3 receptor, FLNa and
-arrestin have been shown to form a signaling complex that is destabilized by
agonist- or expression-meditated increases in G-protein receptor kinase 2/3
(GRK2/3) activity (Kim et al. 2005b). Filamins have also been shown to directly
interact with -arrestin (Scott et al. 2006) and the interaction site has been mapped
to IgFLNa domain 22. G-protein mediated signaling of D2 and  D3 receptors is
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terminated by binding of -arrestin after GRK2/3 mediated phosphorylation of the
receptors. This pathway can also proceed forward to endocytosis of -arrestin–
receptor complexes. Filamins may regulate the stability of receptor–G-protein
signaling complexes, and in this way contribute to sensitization and desensitization
of the D3 receptors. It has been shown that physical interaction between FLNa and
phosphorylated D3 receptor is likely to participate in sequestration of D3 receptors
(Cho et al. 2007).
Fig. 17 The topology of D2 dopamine receptors and the location of FLNa binding
site. D2 receptors contain seven transmembrane (TM) helices. N-terminus is located
at the extracellular space and C-terminus is inside cell. Filamin binding site is
located at the third intracellular loop close to the TM helix 5.
Another pharmacologically important filamin-binding GPCR is -opioid
receptor (Onoprishvili et al. 2003; Onoprishvili and Simon 2007; Onoprishvili et al.
2008) and also in this case FLNa is involved in receptor regulation and trafficking.
The -opioid receptor interaction site has been mapped to FLNa H2 and IgFLNa24.
Interestingly, the opioid antagonist naloxone has also been shown to interact with
this region of FLNa (Wang et al. 2008; Wang and Burns 2009).
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3.4. Why All These Modules and Interactions?
We have seen that, in addition to being complex multi-domain proteins, filamins are
indeed also multi-functional. All these modules and interactions raise a question
over the fundamental role and purpose of filamins. Filamins clearly contribute to
actin organization in a unique way and this is reflected in impairment of cell
morphology and locomotion in filamin depletion. Filamins therefore have a
mechanical role in the integrity of cytoskeleton. Filamins also serve as a link
between the cytoskeleton and the cell membrane. They mechanically link several
cell membrane receptors, participating both in cell adhesion and signaling, to the
inner structures of the cell. Recently, it has been shown that filamins participate in
caveolae internalization and trafficking (Sverdlov et al. 2009). Besides their
mechanical role, filamins also function as a communicational link through
coordinating organization of intracellular signaling intermediates around the
receptors—they are signaling scaffolds. Filamins participate in physical connection
and communication between the extracellular matrix and the cytoskeleton. Filamins
are integrators of cell mechanics and signaling (Stossel et al. 2001). Several
diseases linked to filamin defects reflect the importance of these proteins in
development and physiology, and give clues about the roles of different filamin
interactions. It is worth noting that several disease-causing filamin mutations are
located at the N-terminal part of rod domain 1 (see Table 3), but there are not many
interactions mapped to this area (see Table 5), nor there are many structures of these
domains (see Table 4). These domains must, however, have a significant role if
minor point mutations in the amino acids produce such drastic phenotypes. It
remains to be seen whether filamin interactions, e.g., physical contacts with
GPCRs, could be targeted and exploited for pharmacological and
pharmacotherapeutic purposes.
One of the open questions is also how filamin interactions are regulated.
We have seen some examples of alternative splicing, proteolytic cleavage and
phosphorylation but these mechanisms are not quite clear yet. Also, receptor
occupancy, i.e., competition between several ligands for the same binding site, has
been shown to play a role in filamin interactions. Mechanical forces as filamin
regulators have been implied in several studies. Filamin could have a role in
mechanosensory signaling and mechanotransduction or even in mechanoprotection
of cells from apoptosis (Glogauer et al. 1998). Recent findings on structures of
multi-domain filamin constructs provide potential explanations of how mechanical
stretching could regulate interactions. Regulation by mechanical forces could be
structurally executed through inter-domain reorganization and controlled reversible
unfolding of the domains. All this is crucial evidence of the fact that in order to
fully understand the function of a protein, one needs to know its structure—and
understand it. Structures of isolated FLN domains do provide clues on the
molecular mechanisms of filamin functions, but thorough understanding of the
function of this multi-module system necessitates knowledge of the complex inter-
module structure, dynamics, and energetics of the entire filamin dimer.
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4. NMR SPECTROSCOPY OF MULTI-DOMAIN
PROTEINS
4.1. Protein NMR Spectroscopy Basics
X-ray crystallography has dominated protein structure determination for decades.
During the last two decades, NMR spectroscopy has, however, evolved into a
powerful structure determination technique complementing protein crystallography
(Downing 2004; Cavanagh et al. 2006). Besides structure determination, NMR
spectroscopy is also a versatile and efficient technique for studying protein
interactions and dynamics, and providing the means to understand protein function
(Grzesiek and Sass 2009). One of the strengths of protein NMR spectroscopy is that
proteins can be studied in solution state close to physiological conditions. In the
early years of protein NMR spectroscopy the technique was only applicable for
small proteins. Since then, this method, and the biochemical and technical tools
supporting it, have advanced a great deal and nowadays, relatively large protein
systems can be studied by NMR. There are examples of  NMR studies  of  proteins
inside living cells—in the most natural environment of proteins where they are
accompanied by a range of other cellular components (Dötsch 2008; Sakai et al.
2006; Inomata et al. 2009; Sakakibara et al. 2009). In addition, membrane proteins,
pharmacologically important target proteins which have been regarded as difficult
cases by both X-ray crystallographers and NMR spectroscopists, can be studied by
NMR both in solution and in solid state (Opella and Marassi 2004; Sanders and
Sönnichsen 2006; Hiller and Wagner 2009; McDermott 2009). It is worth
mentioning that biomolecular solid state NMR spectroscopy has evolved with large
leaps during the last decade (Baldus 2006; McDermott and Polenova 2007;
Middleton 2007). This thesis will, however, focus on solution state protein NMR
spectroscopy.
There are some well known requirements and limitations in protein studies
with NMR. The first requirement for detailed protein NMR studies is isotopic
labeling of the target protein with NMR active isotopes 13C and/or 15N (Ohki and
Kainosho 2008). Some preliminary screening is of course possible with a non-
labeled sample using simple 1H experiments, but more advanced multi-dimensional
heteronuclear NMR studies necessitate isotopically labeled protein. Usually
samples are produced using well-established methods of heterologous recombinant
protein production in Escherichia coli, but some other organisms and methods can
also be used. The amount of sample needed to obtain NMR data in a reasonable
time is rather large—the rule of thumb is often 250 l of 0.5–1 mM protein sample,
but this requirement has also been partly overcome by the latest technical
improvements. The well known limitation of NMR studies is protein size. There is
no hard-limit of protein size in NMR, but smaller proteins are easier and more
straightforward to cope with, whereas a large size necessitates usage of special
techniques in sample preparation and data acquisition, and can hinder the use of
some techniques and studies. In order to proceed with sophisticated protein NMR
studies, one has to have long-lasting good spectrum quality (i.e., well-resolved
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signals with high chemical shift dispersion and uniform intensities), which is an
indication of a correctly folded, non-aggregated, and stable protein sample.
Unfortunately, too often this is not the case. One can, usually by a trial and error
approach, play around with protein construct size and sample conditions; i.e., buffer
type and concentration, pH, temperature, salt type and concentration, and presence
of some additives; to fulfill the spectrum quality standards, but in some cases this
will not give enough improvement.
If one is fortunate and obtains a well-behaved isotopically labeled protein
sample, the next goal is usually resonance assignment—depending on application,
either sequential assignment of the backbone resonances or full assignment of all
resonances, including side chains. In the most favorable cases, i.e., when spectrum
quality is good enough, resonance assignment and even the whole structure
determination process can be automated (Güntert 2009). There are several good
books and reviews on NMR experiments and techniques used in protein studies
(e.g., Sattler et al. 1999; Berger and Braun 2004; Downing 2004; Permi and Annila
2004; Cavanagh et al. 2006). This thesis will not cover the basics of protein NMR
spectroscopy in detail but will give a brief overview of NMR spectroscopic
techniques that can be used in studies of protein structure, dynamics and
interactions. More emphasis will be given to special techniques used for large
modular protein systems.
4.1.1. Protein Structure Determination
Protein structure determination requires relatively concentrated and stable 13C,15N-
labeled protein sample giving good spectra. Almost complete chemical shift
assignments of the backbone and side chain signals are required to get reliable
structure determination outcomes. Traditional structural restraints of NMR
spectroscopic protein structure determination are distance restraints between proton
pairs obtained from correlation peak intensities of 13C- and 15N-edited 3D NOESY
spectra. The signal intensity of these spectra exploiting the nuclear Overhauser
effect (NOE) is inversely proportional to the distance between the two protons
(~r 6), so that only protons closer than ~6 Å produce detectable correlations. These
data can then be used as distance restraints in molecular dynamics, e.g., torsion
angle dynamics, -based structure calculations. Thus, NMR-based protein structure
determination is always partially molecular modeling which is distinct from X-ray
crystallographic structure determination. Several software are available for NMR
structure calculation of biomolecules, e.g., CYANA (Herrmann et al. 2002; Güntert
et al. 2004), ARIA (Habeck et al. 2004), and Xplor-NIH (Schwieters and
Kuszewski 2006). In addition to NOE-based restraints other restraint types can also
be used; e.g., dihedral angle restraints, either measured through J-couplings or
calculated based on secondary chemical shifts (Shen et al. 2009) and hydrogen
bond restraints, either measured (Cordier and Grzesiek 1999) or estimated based on
e.g., proton exchange rates. Other types of structural data can also be obtained with
NMR experiments, e.g., information on protonation and tautomeric state of
histidine side chains (Shimba et al. 1998; Sudmeier et al. 2003); which, for that
matter, is not detected in X-ray crystallography; and on configuration of proline
rings (Schubert et al. 2002). The problem with all the above mentioned restraints is
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that they provide relatively short-range structural information. This poses a
problem; especially in structure determination of large proteins and modular
systems, where potential errors and uncertainties in short range restraints may
accumulate, producing imprecise or even incorrect results. New methods, e.g.,
residual dipolar couplings (RDC) and paramagnetic probes, have been exploited to
obtain long-range structural information (see Chapter 4.2.3).
NMR spectroscopic protein structure determination is by no means finished
after basic structure calculation, but the ensemble of structures still has to be
refined. The initial structure calculation is usually speeded up and made
computationally lighter by making approximations in molecular representations,
especially in non-bonded interactions such as electrostatic and van der Waals
forces. In order to obtain physically more realistic structure models usable for
further applications, the structure has to be refined using full molecular dynamics
force fields (Xia et al. 2002; Linge et al. 2003). The final stage of structure
determination is quality control and validation of the structure ensemble (Spronk et
al. 2002). Unfortunately, too many NMR protein structures in the PDB database
have not gone through these last two important steps of protein structure
determination and thus may contain unreliable or even misleading structural
information. There is a separate database, DRESS, for refined solution NMR
structures (Nabuurs et al. 2004). WHAT_CHECK and PROCHECK are tools for
easy and quick evaluation of protein structure quality (Hooft et al. 1996; Laskowski
et al. 1996). Also guidelines for representation of NMR structures have been
presented to facilitate quality estimation of published results (Markley et al. 1998).
NMR spectroscopic protein structure determination is a rather time-
consuming and labor-intensive task. The number of structure determination targets
is growing rapidly due to efficient structural genomics techniques and demand for
high-throughput structure determination protocols is increasing. Several steps of
NMR structure determination, e.g., peak picking and resonance assignment, are
straightforward and even trivial assuming that the spectrum quality is high, which
means that the process can be automated. Several automation protocols and
programs exist  for NMR data analysis (Altieri  and Byrd 2004; Donald and Martin
2009) and NMR structure determination process (Gronwald and Kalbitzer 2004;
Güntert 2009). Using these automated methods NMR spectroscopy could evolve
into high-throughput structure determination tool for structural proteomics (Shin et
al. 2008). Recent studies have also revealed the potential of structural information
contained in chemical shifts in protein structure determination (Cavalli et al. 2007).
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Fig. 18 Flowchart of NMR spectroscopic protein structure determination. Dashed
arrows represent potential iterative cycles of the process.
4.1.2. Interaction Studies
NMR spectroscopy is a versatile tool for studying protein interactions (Zuiderweg
2002; Takeuchi and Wagner 2006). Interaction partners may include
macromolecules; such as other proteins, nucleic acids and carbohydrates; molecular
assemblies; like cell membranes; and small molecule ligands. The strength of NMR
spectroscopy in protein interaction studies is that it gives relatively easily
information on binding site and mode, and it is also powerful for detecting
interactions between weakly binding components with dissociation constant Kd >
10 4 M (Vaynberg and Qin 2006). Several NMR methods, each suited for different
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combinations of settings and goals, are available for protein interaction studies
(Table 6). NMR spectroscopy can be efficiently used in drug discovery, particularly
for lead screening and optimization (Stockman and Dalvit 2002; Zerbe 2003; Lepre
et al. 2004; Peng et al. 2004; Skinner and Laurence 2008). Drug screening can be
performed either by protein-detected experiments, which can give detailed
structural information on the interaction, or by ligand-detected techniques, which do
not necessitate protein isotope-labeling or assignment. Many of the ligand-based
experiments work only for ligands with Kd values of 10 6 10 3 M  so  they  are
unable to detect strongly binding ligands with slow dissociation rates. Protein-
detected experiments suffer from the same size limitations as all protein NMR
experiments.
In many cases the ultimate goal of interaction studies is structure
determination of the protein complex (Nietlispach et al. 2004; Bonvin et al. 2005).
In order for the intermolecular NOEs to be detectable the complex has to be
relatively tight with Kd below the micromolar range. Whereas the X-ray
crystallographic complex structure determination follows the same protocol as with
lone proteins, NMR spectroscopic complex structure determination often requires
special techniques; such as differential labeling of the components, isotope-filtered
experiments (Breeze 2000), and probably also use of additional structural restrains
like residual dipolar couplings (see Chapter 4.2.3) (Clore 2000; Skrynnikov 2004)
and paramagnetism-based restraints (Pintacuda et al. 2007). Simple chemical shift
perturbation data can be also used for NMR-guided docking of the interaction
partners to obtain a model of the complex structure, e.g., using program
HADDOCK (McCoy and Wyss 2002; Dominguez et al. 2003). This method
enables the structure determination of weak complexes.
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Table 6 NMR experiments to detect and characterize protein interactions. Gray





High sensitivity. Small amount of receptor needed.
Saturation transfer from protein to ligand.
Binding site determination with SOS-NMR.
Mayer and Meyer 1999;




Only small amount of target needed. Provides information on
binding conformation. Post 2003
WaterLOGSY Selective magnetization transfer from bulk water via theprotein–ligand complex to the free ligand.
Dalvit et al. 2000;




Relaxation and diffusion rates of small ligands are altered by
binding to macromolecules. Hajduk et al. 1997





Protein attached paramagnetic spin label considerably
enhances the relaxation rates of a binding ligand.
Jahnke et al. 2000;




Able to detect tight-binding ligands.
Provides rapid estimate of the binding constant.
Dalvit et al. 2002a;
Dalvit et al. 2002b
Chemical shift
perturbations
Requires protein isotope labeling.
Gives estimation of binding affinity.
Gives detailed information on binding site if protein
assignments are available.
Can enable complex structure determination using NMR-
guided docking.
Shuker et al. 1996;
McCoy and Wyss 2002;





Identification of binding sites in protein complexes.
Requires isotope labeling.
Experiment is based on STD.
Nakanishi et al. 2002
Differential line
broadening
Binding epitope mapping of small (protein) ligand binding to a
larger protein.
Requires isotope labeling of the ligand protein.
Experiment is based on enhanced relaxation at the residues at
the binding epitope.




Determination of the dihedral angles of the bound
conformation.
Requires isotope labeling of the protein.





Structure calculation based on intermolecular NOEs, RDCs
and/or PRE restraints.
Yields atomic resolution structure of the complex.
Nietlispach et al. 2004
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4.1.3. Protein Dynamics
NMR spectroscopy is an excellent tool for studying the dynamic behavior of
proteins and other biomolecules. Various types of NMR experiments provide
information on protein motions on a broad range of timescales (Fig. 19) (Palmer
2004). Dynamics of protein folding can be also studied using NMR methods
(Dyson and Wright 2004; Neudecker et al. 2009). NMR studies of nascent protein
chains still attached to ribosomes have been conducted to understand co-
translational protein folding (Hsu et al. 2007). A rather large share of proteins exists
in cells as natively unfolded polypeptides. NMR spectroscopy has been employed
to characterize the conformations of these highly dynamic molecules (Meier et al.
2008). Knowledge of protein dynamics provides insight into protein interactions as
the dynamical behavior of the binding site residues is often distinct from the rest of
the protein, and ligand binding can have an effect on the relaxation properties of the
protein. Deeper understanding of enzyme function, which is an inherently dynamic
process, can be gained through NMR spectroscopic analysis of enzyme dynamics
(Boehr et al. 2006). NMR analysis of protein dynamics can also provide
information on the effects of mutations on protein structure and stability (Adams et
al. 2004).
Fig. 19 NMR data timescale versus protein dynamics timescale. Reprinted and
adapted with permission from (Boehr et al. 2006) © 2006 American Chemical
Society.
Fast backbone and side chain motions can be studied by measuring
relaxation rates; longitudinal relaxation rate R1 and transverse relaxation rate R2;
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and steady-state heteronuclear NOEs (for a review of NMR studies of fast time-
scale dynamics of protein backbones see Jarymowycz and Stone 2006). Most often
the relaxation measurements are done for backbone 1H–15N bond vectors using
1H,15N-HSQC-based experiments, but also other sites and nuclei combinations can
be studied in a similar fashion and they often provide deeper and more detailed
insight into protein dynamics (Igumenova et al. 2006). Relaxation rates provide
information on motions in fast sub-ns and slow s–ms time scales. They also reflect
the overall rotational diffusion of the molecule, which is related to its size and
shape. Relaxation data is often analyzed using Lipari–Szabo model-free formalism
(Brüschweiler 2003). This analysis generates dynamic parameters of the protein:
generalized order parameter, S2, which describes internal motions of the protein so
that value 1 denotes an absolutely rigid structure and value 0 completely free and
random motion; e is the timescale for the internal bond vector motion; and Rex
describes relaxation due to conformational exchange in s–ms timescale. Model-
free analysis requires estimation of the rotational diffusion tensor of the protein. A
rough estimate is usually easily obtained from analysis of R2/R1 ratios of the rigid
residues. Problems might be encountered in the case of highly isotropic systems or
proteins undergoing large-scale internal motions. Model-free analysis provides only
an  estimation  of  Rex and as many important biological processes occur at s–ms
timescales, other methods are needed to characterize these motions. R  and R2
relaxation dispersion analysis gives a more detailed insight into these dynamic
processes (Palmer et al. 2001; Palmer and Massi 2006). These techniques have been
used to characterize the dynamics of enzyme catalysis, a process involving motions
in a wide range of timescales (Henzler-Wildman et al. 2007).
Very slow (ms–days) protein motions are reflected in chemical shifts and
proton chemical exchange rates. If the protein under study undergoes slow motion
between two states, separate signals can be detected for both forms. Sequential
acquisition of NMR spectra, especially when implemented with fast-pulsing multi-
dimensional techniques (Schanda 2009), can be used to follow processes slower
than R1 and R2. Backbone amide proton exchange rates provide information on fold
stability and on local structural fluctuations, e.g., dynamics at secondary structure
level. Relatively fast amide proton exchange rates (5–500 ms) can be studied by
following the exchange of amide proton magnetization with magnetization of water
protons (Dempsey 2001). Slow amide proton exchange is most easily observed
through measuring a series of 1H,15N-HSQC spectra of a protein freshly exchanged
from water into D2O, and following the loss of amide proton signal intensities.
Besides their popular use as structural restraints (see Chapter 4.2.3) residual
dipolar couplings can also be employed to gain information on protein dynamics
(Deschamps et al. 2005; Tolman and Ruan 2006). RDCs provide information on
motions at ps–ms timescale and their strength is that they also cover the ns– s area
which is not amenable to other NMR methods. Thus RDCs can be used to study
slow correlated motions often involved in enzyme catalysis, signal transduction,
ligand binding and allosteric regulation (Bouvignies et al. 2005). Recently
developed methods enable simultaneous determination of protein structure and
dynamics using RDC data (Bouvignies et al. 2007).
NMR spectroscopy of multi-domain proteins
50
4.2. Tricks for Large Proteins
It is a well known fact that size matters in protein NMR spectroscopy. But large
size is no longer an absolute obstacle—it just makes things more complicated and
restricts what can be done. Nowadays there are several tricks that can be employed
to enable NMR studies of large proteins (Foster et al. 2007). The principal problem
with high-molecular weight proteins in NMR is their slow tumbling rate, which
causes fast relaxation of transverse magnetization. This problem has been tackled
with protein deuteration and with transverse relaxation-optimized spectroscopy
(TROSY). Another complication is crowded spectrum, i.e., severe resonance
overlap. Additional spectrum dimensions and ingenious isotope labeling approaches
have been employed to overcome this problem. There are now examples of NMR
studies of huge protein assemblies (Luy 2007).
Presently the largest NMR-derived structures in the PDB database are:
maltose binding protein (370 residues, PDB accession code 2H25); E. coli
transhydrogenase (393 residues, PDB accession code 2BRU); E. coli HSP70
(DNAK) chaperone (605 residues, PDB accession code 2KHO); and malate
synthase G (MSG) (723 residues, PDB accession codes 1Y8B and 2JQX). To date,
MSG is the largest protein whose structure has been determined using NMR
spectroscopy. Virtually complete backbone chemical shift assignment of MSG was
accomplished using 4D TROSY spectra and selective labeling strategies (Tugarinov
et al. 2002). Residual dipolar couplings and carbonyl chemical shift changes of
MSG were determined in Pf1 phage alignment medium to extract the orientational
restraints for structure calculation (Tugarinov and Kay 2003a; Tugarinov and Kay
2003b). Global fold of MSG was determined using combination of different
restraints: limited set of NOEs, hydrogen bond and dihedral angle restraints, RDC
and carbonyl chemical shift anisotropy restraints, and radius of gyration (Tugarinov
et al. 2005). Later the structure was also refined against combination of NMR and
small-angle X-ray scattering restraints (Grishaev et al. 2008).
The following chapters are devoted to recent advances in NMR
spectroscopy that are especially useful in NMR studies of large protein systems.
4.2.1. Sample Preparation
During the last decade, a number of new isotope labeling strategies have been
employed to enable NMR studies of large protein systems (Ohki and Kainosho
2008). Deuteration can be used to simplify 1H  NMR  spectra  for  example  in
interaction studies but more often the purpose of deuteration is to damp down
protein transverse relaxation. Perdeuteration, i.e., full deuteration, or random
fractional deuteration can be used for the latter purpose. The problem with
deuteration is that the proton density giving rise to rich NOE distance information is
lost, which complicates structure determination. Several ingenious selective isotope
labeling strategies, e.g., amino acid-type and methyl group-selective and stereo-
specific labeling schemes, have been exploited in NMR studies. Segmental labeling
has become available after the development of intein technology (Iwai and Züger
2007).
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The traditional, and still the most popular way of making isotope-labeled
proteins for NMR spectroscopy is expression in E. coli cells. There are, however,
some problems with prokaryotic organisms regarding protein folding and post-
translational modifications. Thus, some other cells, e.g., Pichia pastoris and
Baculovirus-infected insect cells, have also been employed in protein production for
NMR spectroscopy (Ohki and Kainosho 2008). Cell-free protein production uses
the translation machinery of cells in vitro without the cell itself (Spirin and Swartz
2008). This method is also now used in NMR sample preparation and it can be
exploited in versatile labeling schemes (Staunton et al. 2006). Recent developments
in the cell-free systems to expand the genetic code might bring innovative labeling
schemes for NMR spectroscopy (Wang et al. 2006; Gáspári et al. 2008).
4.2.2. On the Spectrometer
Technical advancements in NMR spectrometers and experiments have facilitated
studies of large protein systems. Nowadays spectrometers with 1H frequencies up to
1 GHz are commercially available. Higher field strengths alleviate resonance
overlap and enhance sensitivity. Substantial sensitivity enhancement has been
gained with cryogenically cooled probeheads (Webb 2006) which enable studies of
more dilute protein samples. This means that a smaller amount of expensive
isotope-labeled protein is needed, and protein aggregation problems can also be
alleviated. Dynamic nuclear polarization (DNP) has been exploited to enhance
NMR sensitivity especially in solid state and small-molecule solution state NMR
(Maly et al. 2008). Recent studies have demonstrated the feasibility of DNP-
enhanced high-field NMR in aqueous solutions suitable for biomolecular studies
(Prandolini et al. 2009).
Three-dimensional NMR experiments are commonplace in protein studies,
but even fourth dimension has been introduced to avoid resonance overlap and
provide more specific data for resonance assignment (Konrat et al. 1999; Yang and
Kay 1999). New pulse sequences have been developed to take full advantage of the
selective isotope labeling schemes (Ohki and Kainosho 2008). Isotope-filtered
experiments are exploited in extracting intermolecular NOEs for structure
determination of protein complexes (Breeze 2000).
Probably the most important invention for NMR studies of large proteins
has been transverse relaxation-optimized spectroscopy (TROSY) (Pervushin et al.
1997). TROSY is especially suited to large deuterated proteins and high
spectrometer frequencies (Fernández and Wider 2003). Several pulse sequences
utilizing TROSY scheme have been designed for protein studies (Zhu and Yao
2008). TROSY technique can be combined with polarization transfer by cross-
correlated relaxation (CRINEPT) scheme to study even larger systems (Riek et al.
1999; Riek et al. 2002). This method enables NMR studies of systems with
molecular weights approaching MDa—structure determination will probably not be
feasible, but at least some useful information can be gained.
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4.2.3. Long-range Conformational Restraints
The problem with traditional NOE-based distance restraints is that they provide
only short-range structural information. In large systems, errors and uncertainties
may accumulate, producing imprecise or even incorrect structural results.
Intermolecular and inter-domain NOEs, which are usually long-range NOEs, are
often difficult to detect due to their weak intensities. NOEs might be also absent due
to dynamical behavior of the interface. This has created demand for long-range
structural restraints for NMR spectroscopic protein structure determination.
Residual Dipolar Couplings
The principle of measuring anisotropic interactions of small organic molecules in
liquid crystalline media using NMR spectroscopy was demonstrated several
decades ago (Saupe and Englert 1963). The applicability of the phenomenon to
obtain structural restraints for biomolecular structure determination was presented
in the 1990s (Tolman et al. 1995). Residual dipolar coupling (RDC) and NOE
restraints are different by nature: NOEs provide distance between two nuclei
whereas RDCs represent orientation of a vector between two nuclei, which means
that these methods provide highly complementary structural information. This is
one of the reasons why RDCs have become so popular in biomolecular NMR
studies. Strengths of RDC restraints include that they provide long-range structural
information and RDCs can be also measured for heteronuclei, not just for protons,
which is important in highly deuterated samples. Several excellent reviews exist on
protein structure determination using RDC restraints (Lipsitz and Tjandra 2004;
Prestegard et al. 2004). As mentioned earlier, protein dynamics can also be studied
using RDCs (Tolman and Ruan 2006; Bouvignies et al. 2007).
The theory and applications of RDCs has been beautifully represented in a
review article by Blackledge (Blackledge 2005). The basic principle of RDC









2 cos 2 , (1)
where rij is the distance between the two nuclei; i and j are the gyromagnetic ratios
of the two spins; h is Planck’s constant; 0 is the permittivity of free space; and
are defined in Fig. 20; and Aa and Ar are the axial and rhombic components of the
alignment tensor, respectively. Alignment tensor describes the extent and nature of
protein alignment and it is determined by the size and shape of the protein and by
the properties of the alignment medium.
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Fig. 20 The principle of RDC restraints. (A) Dependence of RDC values on the
orientation of the inter-dipolar vector (angles  and ) and the alignment tensor
with eigenvalues Axx,  Ayy and Azz. The sphere depicts the range of RDC values
(categorized for clarity) for different vector orientations. (B) The degenerate
orientations resulting in equivalent RDC values. Reprinted and adapted with
permission from (Blackledge 2005). © 2005 Elsevier.
Magnetic susceptibility anisotropy of some metalloproteins and nucleic
acids can be large enough to provide natural alignment in magnetic field to enable
measurement of RDCs, but for most proteins artificial alignment is needed, as
normally proteins tumble randomly in the isotropic solution and RDCs average out.
Several alignment media are available for introduction of small anisotropy for RDC
measurement (see Prestegard et al. 2004 for comprehensive list of available media
and description of their properties) and also paramagnetic tags can be used for
protein alignment (see below). The most popular alignment media are phospholipic
bicelles (Ottiger and Bax 1998), filamentous Pf1 bacteriophages (Hansen et al.
1998) and stressed polyacrylamide gels (Sass et al. 2000; Tycko et al. 2000). RDCs
can be measured in theory between any NMR active atom pairs, but largest, and
thus easiest and most accurately determined, RDCs are observed between directly
bonded 1H–15N and 1H–13C pairs. Several pulse sequences have been developed for
the measurement of RDCs (Hu and Wang 2006). TROSY-based HNCO
experiments are especially well-suited for particularly large proteins (Yang et al.
1999; Kontaxis et al. 2000; Permi et al. 2000). Another related orientation-
dependent feature that becomes available in partially aligned protein samples is
non-averaged carbonyl chemical shift anisotropy, which is manifested as a residual
chemical shift difference between the isotropic and anisotropic states (Cornilescu et
al. 1998).
Paramagnetic Probes
At first paramagnetic proteins were regarded as problematic for NMR spectroscopic
studies as paramagnetic centers induce paramagnetic relaxation enhancement
(PRE), which substantially enhances nuclear relaxation and thus complicates NMR
analysis. Protein NMR spectroscopists have, however, learned to exploit this
phenomenon for several purposes. Proteins can be oriented in a magnetic field for
RDC measurement using paramagnetic alignment, but natural paramagnetic metal
cations in protein structures or paramagnetic tags (Su and Otting 2009) also provide
another kind of long-range structural restraints (Bertini et al. 2008). Due to severe
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paramagnetic broadening of 1H signals, 13C direct-detection experiments are
common in studies of paramagnetic proteins. Paramagnetic enhancement of
longitudinal relaxation rates and cross-correlation effects can be used as distance
restraints in paramagnetic proteins (Bertini et al. 2005). Paramagnetic relaxation
enhancement is also an efficient tool to detect molecular interactions (Clore et al.
2007). Certain paramagnetic metal ions have large magnetic susceptibility
anisotropy and they induce position dependent pseudocontact shifts (PCS) on
chemical shifts of nuclei. In favorable cases, pseudocontact shifts can be detected as
far as 40 Å from the paramagnetic center, so they can provide true long-range
restraints.
4.3. The Role of NMR Spectroscopy in Structural and Functional
Studies of Multi-domain Proteins
Multi-domain proteins are almost always rather large systems. For X-ray
crystallographic structure determination, size does not present any problems as
such, but multi-domain proteins are also often somewhat dynamic and this
complicates protein crystallization. NMR spectroscopy does not suffer from
dynamics—on the contrary, it is a rather efficient method for the analysis of protein
dynamics. Crystal structure is in principle just a snapshot of a protein undergoing
conformational exchange. All previously mentioned methods for large-molecule
NMR can be used to enable NMR analysis of modular proteins and NMR
spectroscopy is recognized as a promising method for structural and functional
analysis of multi-domain proteins (Pickford and Campbell 2004).
Several NMR methods can be used in structure elucidation of modular
proteins. The problem with sole NOEs is that in many cases, especially if there are
inter-module dynamics involved, the inter-domain NOEs are scarce. Segmental
labeling is useful in recognizing domain interactions and inter-domain NOEs (Iwai
and Züger 2007). The modular approach is a good way to proceed with structural
studies of multi-domain proteins. One first measures and assigns the spectra of
isolated modules and determines their structures. Chemical shift mapping between
the isolated modules and the multi-domain unit gives clues on domain contacts.
Domain interactions can also be recognized using domain titrations but in some
cases, e.g., if the domain interaction is rather weak and the domain linker has a
crucial role in domain–domain interface, the interaction might not become visible in
the titration. Chemical shift mapping and soft docking methods can be used in
structure determination of multi-module systems (McCoy and Wyss 2002;
Dominguez et al. 2003).
RDCs are especially well suited for structural studies of modular proteins
(Fischer et al. 1999). RDCs provide vital information on domain orientations
(Skrynnikov 2004) and they can also be used to reveal inter-module dynamics
(Braddock et al. 2001). In addition to RDCs, spin relaxation and overall rotational
diffusion tensor also gives structural data on modular assemblies and their dynamics
(Fushman et al. 2004; Ryabow and Fushman 2007). Paramagnetic restraints can be
a valuable source of long-range structural information in structure determination of
modular proteins (Bertini et al. 2008). All this versatile atomic-resolution NMR
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data can be combined with low-resolution structural data from small-angle X-ray
scattering (SAXS). Combination of RDC and SAXS data has been shown to be an
efficient way of solving structures of modular proteins and protein complexes
(Mattinen et al. 2002; Grishaev et al. 2005; Gabel et al. 2008). The power of this
approach in structure determination of large multi-domain proteins has recently
been well demonstrated with the RDC–SAXS-refined 82-kDa structure of MSG
(Grishaev et al. 2008).
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5. AIMS OF THE STUDY
The experimental part of this thesis consists of NMR spectroscopic studies of
human filamin A. Of the three filamin isoforms, we chose FLNa as it is the most
ubiquitously expressed, and several FLNa interactions have been evidenced. As
described in Chapter 3, Filamin A is a modular multi-functional protein with several
interaction partners and versatile functions. NMR spectroscopy was employed to
gain information on structure, interactions and dynamics of the protein in order to
understand its function.
The specific aims of this project were:
(i) Gain high-resolution structural information on IgFLN domains in solution state
(I–II, IV).
(ii) Learn how IgFLN domains interact with other proteins (I, II, IV).
(iii) Find out how consecutive IgFLN domains interact with each other and pack
together to form higher-order structures (III–V).
In the following text the emphasis is laid on protein NMR spectroscopic aspects of
the study, whereas molecular biology of filamins is covered in detail in Chapter 3




A brief overview of the experimental procedures used in the protein NMR studies
presented in this thesis is provided here to support the readability of the following
chapters. More detailed descriptions can be found in the original research articles.
6.1. Expression and Purification of Isotope-labeled Proteins
6.1.1. 15N- and 13C,15N-labeled Protein Samples
The protein constructs used in the studies are summarized in Table 7. All 15N- and
13C,15N-labeled samples used in the study were prepared using essentially the same
procedure. The fragment encoding the FLNa domain was amplified from a cDNA
of human FLNA4 by PCR and cloned to PGEX2T (GE Healthcare Life Sciences)
plasmid. The inserts were verified by DNA sequencing. Protein was produced in
Escherichia coli BL21(DE3) cells in minimal media containing 15NH4Cl and 13C-
glucose (Spectra Stable Isotopes, Columbia, MD) as sole nitrogen and carbon
sources, respectively. Protein expression was induced overnight at 37 °C in the
presence of 0.5 mM IPTG. Cells were harvested and disrupted in PBS by using a
French press. The soluble proteins were separated by ultracentrifugation. The fusion
protein was purified on Glutathione Sepharose 4 Fast Flow column (Amersham
Biosciences) and eluted with 10 mM glutathione in 50 mM Tris-HCl (pH 8.0).
Glutathione S-transferase part of the fusion protein was removed with TEV
protease. Glutathione S-transferase (GST)-His6-tag and His6-TEV were removed
by passing the solution through a Ni-NTA agarose column (Qiagen). The flow-
through fractions were concentrated using an Amicon Ultra-15 (Millipore)
centrifugal filter with a molecular weight cutoff of 5,000 Da and applied onto a
Superdex 75 HR 16/60 (Amersham Biosciences). Purified protein was concentrated
with a Microcon YM-3000 centrifugal filter (Millipore). The point or deletion
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c(protein) = 0.8 mM
50 mM Na-phosphate pH 6.8
100 mM NaCl, 1 mM DTT, 2 mM NaN3,
7% D2O, T = 30 °C, 750 and 800 MHz
Structure determination, titration




















































c(protein) = 0.5 mM (0.4 mM in Pf1 phage)
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100 mM NaCl, 1 mM DTT, 2 mM NaN3,
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IgFLNa16–21 (FLNa residues 1772–2329) (V) was expressed from a pGEX-4T-1
vector with a TEV protease cleavage site using BL21 codon plus cells (Stratagene).
Uniform 2H,13C,15N-labeling was achieved by growing in standard M9 minimal
media with 15NH4Cl and D-glucose-13C6-1,2,3,4,5,6,6-D7 and  D2O to  replace  H2O.
All isotope-labeled chemicals were supplied by Cambridge Isotope Laboratories,
Inc. To achieve higher isotope labeling efficiency, all components of the cell culture
were dissolved in D2O and freeze-dried before use. One fresh colony of transformed
bacteria was inoculated into 5 ml of media containing 25% D2O  as  a  start  point.
When becoming fully grown, a 100- l culture was transferred into another fresh 5
ml  of  media  but  with  50%  D2O; this training procedure was repeated until cells
grew  well  in  100%  D2O. Thereafter, the preparation was scaled up to 1.5 l, and
IPTG was added to induce overnight expression when the OD600 reached 0.9.
Harvested cells were lysed with hen egg lysozyme and freeze-thaw cycles.
Expressed proteins were extracted from cell lysates by vortexing with a large
amount of fresh PBS buffer until no more protein could be detected in the cell
debris on a gel. The protein purification was done as published previously (Kiema
et al. 2006), and the GST tag was removed by the AcTEV protease (Invitrogen).
The sample was further purified by passing down a Superdex 200 column.
6.2. NMR Experiments and Data Analysis
The sample conditions used in the NMR experiments are summarized in Table 7.
NMR spectra were recorded on Varian INOVA 500-, 600- and 800-MHz
spectrometers equipped with 5-mm inverse z-gradient triple-resonance probeheads
and Bruker DRX 750-MHz spectrometer equipped with 5-mm inverse x,y,z-
gradient triple-resonance probehead. The spectra were recorded and processed
using the VNMRJ 2.1 and VNMR 6.1C (Varian Inc.), and XWinNMR 3.0 (Bruker
BioSpin) programs. 1H,15N-HSQC spectrum of IgFLNa23-L2439M sample with
low protein concentration was recorded with Varian INOVA 600-MHz
spectrometer equipped with a 5-mm cryo-probe.  Spectrum visualization and
analysis was done with Sparky 3.110 (Goddard and Kneller 2004). The following
experiments were used for the sequential backbone resonance assignment: 1H,15N-
HSQC, HNCA, HN(CO)CA, iHNCA, HNCACB, CBCA(CO)NH, iHNCACB,
HNCO, HN(CA)CO, and HN(CA)HA (Sattler et al. 1999; Permi and Annila 2004).
Assignment of the aliphatic side chain resonances was performed using the 1H,13C-
HSQC CC(CO)NH, H(CCCO)NH, HCCH-COSY, and HCCH-TOCSY spectra.
The aromatic side chain resonances were assigned using the (HB)CB(CGCD)HD
and (HB)CB(CGCDCE)HE spectra, and the 13C-edited 3D NOESY-HSQC
spectrum. The 15N-edited 3D NOESY-HSQC spectrum was used in the assignment
of His, Asn and Gln side chain N–H groups. The backbone resonance assignment of
2H,13C,15N-IgFLNa16–21 was done using the TROSY versions of 1H,15N-HSQC,




Distance restraints for structure determination were extracted from signal intensities
of the 13C- and 15N-edited 3D NOESY-HSQC spectra. Dihedral angle constraints
for  and  angles were extracted from the chemical shift data using the TALOS
software (Cornilescu et al. 1999). Structure calculation was performed using the
automatic NOE assignment and torsion angle dynamics mode of the CYANA
software (Herrmann et al. 2002). Molecular dynamics refinement of the final
structures was done using a generalized Born implicit solvent model in AMBER 8.0
(Case et al. 2004). Quality of the structure families was verified using
WHAT_CHECK (Hooft et al. 1996) and PROCHECK-NMR programs (Laskowski
et al. 1996).
6.2.2. Interaction Studies
The NMR titrations to reveal FLNa interaction sites were performed by titrating
(13C)15N-labeled protein domain sample step-wise with a concentrated solution of
non-labeled peptide. The peptides were dissolved in the same buffer with the
protein to be titrated. The 1H,15N-HSQC spectrum of the protein was recorded at
every titration point. IgFLNa17 and IgFLNa16–17 samples were titrated with
glycoprotein Ib  peptide (GPIb  residues 556–577) having the sequence
LRGSLPTFRSSLFLWVRPNGRV. Chemically synthesized GPIb  peptide was
provided by Tufts University Core Facility, Boston, USA. IgFLNa23 was titrated
with a peptide derived from FilGAP. FilGAP14 peptide, comprising residues
723EQFFSTFGELTVEP736 of human FilGAP sequence, was purchased from
EZBiolab Inc. IgFLNa19 and IgFLNa18–19 were titrated with integrin 7 peptide
(Ac-776PLYKSAITTTINP788-NH2, numbers denote for residues of human 7
integrin), and dopamine receptor D2 and  D3 peptides  (D2 residues 211–230; D3
residues 210–230). Also dopamine receptor peptides were N-teminally acetylated
and C-terminally amidated. Integrin 7 peptide and dopamine receptor peptides
were purchased from EZBiolab Inc. Combined chemical shift differences of the
backbone N–H signals were calculated as  = ((0.15* N)2+( H)2)½.
6.2.3. Relaxation Rate Measurements
The backbone 15N  R1 and  R2 relaxation rates of IgFLNa17 and 2H,13C,15N-
IgFLNa16–21 were measured with the conventional series of 1H,15N-HSQC
experiments with varied relaxation delays (Farrow et al. 1994). The relaxation rates
of IgFLNa16–17 and 18–19 were measured using the three-dimensional relaxation
rate-resolved 1H,15N-HSQC spectra (Koskela et al. 2004). Inverse Laplace
transform was applied to the relaxation dimension of the three-dimensional datasets
using GIFA software (Pons et al. 1996). The heteronuclear NOEs of the backbone
amide nitrogens were determined using conventional methods (Farrow et al. 1994).
{1H}15N heteronuclear NOEs of 2H,13C,15N-IgFLNa16–21 were measured using




6.2.4. Residual Dipolar Couplings of IgFLNa16–21
To measure residual dipolar couplings, 2H,13C,15N-IgFLNa16–21 was aligned with
Pf1 phage alignment media (Hansen et al. 1998) purchased from Asla Biotech Ltd.
The phage concentration of the aligned sample was 15 mg/ml, and the protein
concentration was 0.4 mM. Scalar and residual dipolar couplings between amide
proton (1HN) and nitrogen (15N) were measured using a modified three-dimensional
HNCO-TROSY-based triple-resonance experiment (Yang et al. 1999; Kontaxis et
al. 2000, Permi et al. 2000). Data sets for selecting TROSY/TROSY and
decoupled/TROSY components in 15N and 1H dimensions were recorded in an
interleaved manner. The residual dipolar coupling contribution to the observed
splitting in phage was obtained by subtracting the 15N–1HN values measured in
water from the values obtained in phage.
Rigid-body modeling of the IgFLNa16–21 domain organization was done
with the MODULE 2 program (Dosset et al. 2001). An arbitrary starting structure
of IgFLNa16–21 (residues 1772–2329) was built using the structures of the IgFLNa
domain pairs 16–17 (PDB accession code 2K7P, model 1, residues 1772–1955),
18–19 (2K7Q, model 1, residues 1956–2136), and 20–21 (2J3S, chain A, residues
2137–2329) by superimposing the overlapping parts of the substructures (IV; Lad et
al. 2007). The structure was divided into six separate modules. The residual dipolar
couplings of the backbone N–Hs were used as restraints in the rigid-body modeling
of the IgFLNa16–21 domain orientations. After the alignment tensors were fitted,
the domains were transformed into a common alignment frame. The inclusion and
exclusion of degenerate orientations were done based on covalent and non-bonded
information and chemical shift perturbations.
6.3. Preparation of Figures
All spectrum illustrations presented in this thesis were prepared with Sparky 3.110
(Goddard and Kneller 2004). The figures representing protein structures have been
created with the MOLMOL (Koradi et al. 1996), Bodil (Lehtonen et al. 2004), and
PyMOL (DeLano 2002) programs. The sequence alignment of dopamine receptor
peptides (Fig. 29) was done using ClustalW2 (Larkin et al. 2007) and visualized
with Jalview version 2 (Waterhouse et al. 2009).
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7. RESULTS AND DISCUSSION
7.1. Structures of Filamin A Immunoglobulin-like Domains and Their
Interactions with Other Proteins
7.1.1. Filamin A Domain 17
Filamin A domain 17 has been shown to interact with the cytoplasmic domain of
glycoprotein Ib  (see Chapter 3.3.2). Our aim was to discover the structural basis of
this interaction (I). As the first step of our study, we determined the structure of
IgFLNa17 (FLNa residues 1763–1756) using NMR spectroscopy. Almost all
backbone amide signals of this 10-kDa Ig domain were visible in the 1H,15N-HSQC
spectrum (Fig. 21) and the spectrum quality was good—an indication of a well-
folded domain. Only residues Q1916 and G1918 could not be detected in the
1H,15N-HSQC spectrum. Virtually complete backbone and side chain assignments
were achieved and deposited in the Biological Magnetic Resonance Data Bank
(BMRB accession code 6730).
The structure of IgFLNa17 was solved using distance restraints derived
from 13C- and 15N-edited HSQC-NOESY spectra. Quality statistics of the structure
family (20 substructures) represent successful structure determination (I: Table 1).
Atomic coordinates of IgFLNa17 structure ensemble are available in the PDB
database under accession code 2AAV. The structure of IgFLNa17 is a traditional
filamin-type  Ig  domain  with  seven   strands  forming  a   sandwich  with  two  
sheets (Fig. 22). There is also a short 310 helix between strands A and A’. Except for
BC and DE loops, which are somewhat looser, the structural precision is good. We
also measured the backbone 15N  T1 and T2 relaxation rates to identify dynamic
residues (I: supplemental Fig. S2). Residues of the BC loop show elevated T2
relaxation rates, which indicates that this loop is flexible. The DE loop does not
have many long-range NOE restraints and thus structural precision in this area is
compromised. The surface of IgFLNa17 has many hydrophobic areas. One is
located at CD face (see Fig. 13) but AG surface also contains several exposed
hydrophobic residues (Fig. 22C).
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Fig. 22 The solution structure of IgFLNa17 (PDB accession code 2AAV) (I). All
panels show the structure from the same perspective. (A) Superimposed backbone
traces of the 20 substructures. Residues 1868–1890, 1899–1911, and 1919–1954
were superimposed. (B) Secondary structure elements of the mean structure. (C)
Surface charge. Blue, positive; Red, negative.
To study the interaction of IgFLNa17 with the GPIb  we titrated IgFLNa17
with a peptide (GPIb 556–577) derived from the cytoplasmic tail of human GPIb
(556LRGSLPTFRSSLFLWVRPNGRV577). Interaction between IgFLNa17 and
GPIb 556–577 was in the slow-exchange NMR timescale and it induced
considerable changes in the 1H,15N-HSQC spectrum of IgFLNa17 (Fig. 23).
Detailed chemical shift mapping was impossible due to drastic chemical shift
changes in several cross-peaks but the most prominent changes seemed to be
concentrated at residues of the CD face which indicates that GPIb  binding site is
located at the CD face of IgFLNa17. There are, however, also notable chemical
shift changes at other parts of the domain, which implies slight structural molding
of the entire domain.
Tight interaction between IgFLNa17 and GPIb  would have enabled NMR
spectroscopic structure determination of the complex. Meanwhile, crystallization of
the IgFLNa17–GPIb 556–577 complex had however proven successful and the
complex structure of IgFLNa17 and GPIb 556–577 was solved using X-ray
crystallography (I). The complex structure confirmed that GPIb  binds to the CD
face of IgFLNa17 (Fig. 13). GPIb  residues 560–573 bind as an additional  strand
to IgFLNa17 strand C. Side chains of GPIb  also interact with the residues of
IgFLNa17 strand D. This interaction closely resembles the structural basis of
filamin dimerization (Pudas et al. 2005) and it is the first structure of IgFLN
domain in complex with an interacting protein. Superposition of the NMR structure
of free IgFLNa17 and the X-ray complex structure (I: Fig. 2C) shows that strand D
slightly moves away from strand C due to peptide binding, but otherwise the two
structures are very similar. Aromatic side chains of GPIb  residues F563, F268 and
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W570 come into close contact with IgFLNa17, which explains the drastic chemical
shift changes induced by the peptide binding.
Fig. 23 Titration IgFLNa17 with GPIb 556–577. Superimposition of the 1H,15N-
HSQC spectra recorded during titration reveals strong slow-exchange interaction.
The most notable chemical shift changes are seen in the residues of the C and D
strands (1894–1914). GPIb 556–577-to-FLNa17 ratios: blue, 0%; red, 60%; black,
100%.
FLNa17–GPIb  interaction seen in the crystal structure was validated using
point mutations which would disturb the interaction and prevent GPIb  binding (I).
G1897 and C1912 are spatially closely located at IgFLNa17 strands C and D,
respectively (Fig. 13). Double-mutant G1897D+C1912D was shown to abolish the
interaction between FLNa and GPIb . We wanted to confirm that this effect was
not due to an impaired domain folding. We checked the 1H,15N-HSQC spectrum of
IgFLNa17 G1897D+C1912D double-mutant (Fig. 24). Spectrum comparison
between native FLNa17 and the mutant shows that the domain is properly folded
and the chemical shift changes are confined to the spatial proximity of the point
Results and discussion
66
mutations. To conclude, the NMR spectroscopic studies of IgFLNa17 support the
IgFLNa17–GPIb  interaction seen in the crystal structure. In the IgFLNa17 project
we nicely combined NMR spectroscopy and X-ray crystallography to gain detailed
information on the structure and interactions of the protein.
Fig. 24 Proper folding of IgFLNa17 double-mutant G1897D+C1912D was checked
using 1H,15N-HSQC spectrum. Overlay of the 1H,15N-HSQC spectrum of native
IgFLNa17 (black) and of the mutant (red). The majority of signals have retained
their positions and large chemical shift changes are confined to the residues in close
proximity to the mutated residues, indicating that the mutant retains the folding of
the native domain. However, signals of the mutant are broadened compared to the
native FLNa17, which implies some protein aggregation.
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7.1.2. Filamin A Domain 23
IgFLNa domain 23 has been shown to interact with FilGAP (Ohta et al. 2006) and
patient mutations associated with PVNH and FMD have been mapped to this
domain (Zenker et al. 2004; Robertson et al. 2006). We wanted to study the
structure of IgFLNa23 in order to understand the structural basis of the interaction
with FilGAP and the structural effects of the disease-causing mutations (II). We
determined the solution structure of IgFLNa23 (FLNa residues 2427–2522) using
NMR spectroscopy. The spectrum quality of IgFLNa23 was excellent (Fig. 25) and
essentially complete chemical shift assignments were obtained (BMRB accession
code 15777).
Fig. 25 The 1H,15N-HSQC spectrum of IgFLNa23 with backbone resonance
assignments (II).
The structure of IgFLNa23 was solved using NOE-distance restraints from
13C- and 15N-edited HSQC-NOESY spectra. Due to excellent spectra, the structure
determination of IgFLNa23 was straightforward and yielded a structure of excellent
quality (Fig. 26; II: supplemental Table S1). Atomic coordinates of IgFLNa23
structure ensemble have been deposited in the PDB database (PDB accession code
2K3T). Like IgFLNa17, IgFLNa23 also holds the traditional IgFLN fold. Structural
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precision is excellent throughout the sequence and side chain conformations in the
hydrophobic core are also defined with high precision (Fig. 26A).
Fig. 26 The solution structure of IgFLNa23 (PDB accession code 2K3T) (II). All
panels show the structure from the same perspective. (A) Superimposed backbone
traces of the 20 substructures. Superposition was done for residues 2427–2520.
Some of the side chains forming the hydrophobic core are also shown. (B)
Secondary structure elements of the mean structure. L2439 is represented with stick
model. (C) Structure superimposition of the three IgFLN23 isoforms: red,
IgFLNa23; blue, IgFLNb23 (PDB entry 2EEC); black, IgFLNc23 (PDB entry
2D7Q). The inset shows sequence alignment of the isoforms. Non-conserved
residues of the CD face are shown with stick models and labeled with FLNa residue
codes. Reprinted and adapted with permission from (Nakamura et al. 2009). © 2009
Nakamura et al.
The interaction of IgFLNa23 with FilGAP was studied using NMR
titrations. FLNa–FilGAP interaction was delineated to the 32 C-terminal residues of
FilGAP (residues 717–748). This peptide, however, turned out to be highly
insoluble in the buffer used for the NMR samples of IgFLNa23 and could not be
used in titrations. We titrated IgFLNa23 with a more soluble shorter FilGAP
peptide (FilGAP14), comprising the residues 723EQFFSTFGELTVEP736. Titration
data indicated interaction at the fast-to-intermediate exchange region, i.e., having a
micromolar Kd.  High  excess  of  FilGAP14 was  needed to  see  clear  changes  in  the
spectrum. Many 1H,15N-HSQC signals disappeared or divided into several peaks
upon addition of FilGAP14 (II: supplemental Fig. S3). Spectrum quality suffered
from addition of the peptide and chemical shift changes were difficult to follow.
The most explicit changes were seen close to the CD face (II: Fig. 3), which also
proves that the interaction between IgFLNa23 and FilGAP follows the general
IgFLN interaction mode (Pudas et al. 2005; Kiema et al. 2006; Nakamura et al.
2006; Lad et al. 2008; Takala et al. 2008; Ithychanda et al. 2009a). As the
interaction between IgFLNa23 and FilGAP14 was relatively weak and spectrum




FilGAP was shown to selectively interact with FLNa and not with FLNb or
FLNc (II). The selectivity of the interaction is remarkable as the structures of the
three IgFLN23 isoforms are very similar (Fig. 26C). There are few non-conserved
residues at the CD face, which is the FilGAP binding site, but they are still able to
delimit the interaction. Isoform-distinctive point mutations A2461T and Y2483H
were shown to be enough to disrupt the FLNa–FilGAP interaction. Selectivity of
FLNa–FilGAP interaction is a fine example of subtle structural features defining
selectivity of protein–protein interactions.
The interaction of FLNa and FilGAP was further characterized using
molecular modeling (II). Based on the crystal structure of IgFLNa17–GPIb
complex, in silico model of IgFLNa23–FilGAP complex was solved to understand
the details of the interaction between FLNa and FilGAP (II: Fig. 3 and
supplemental Fig. S4). IgFLNa23 residue M2474 is in close contact with FilGAP
(Fig. 26C). As we were not able to determine the structure of FLNa–FilGAP
interaction complex experimentally, we wanted to verify our interaction model with
M2474E mutation. FLNa M2474E mutant was incapable of binding FilGAP, which
confirms that the CD face of IgFLNa23 is indeed the binding site for FilGAP.
Proper folding of IgFLNa23 domain was confirmed with NMR characterization of
IgFLNa23 M2474E mutant (II: supplemental Fig. S5). The spectrum of the mutant
proteins shows the properly folded domain and all chemical shift changes are
located in close proximity to the mutated residue. M2474E point mutation does not
perturb folding of IgFLNa23.
We also used NMR spectroscopy to study the effects of IgFLNa23 patient
mutations on the structure of the domain (II). Zenker et al. have described FLNa
mutation 7315C A that leads to two aberrant transcripts: one with seven-residue
(2439–2445) deletion ( 7), and one with L2439M point mutation (Zenker et al.
2004). Point mutant L2439M is thought to be the cause for gain-of-function type
effects observed in FMD, and deletion mutant 7 the cause of the loss-of-function
phenotype PVNH. Residues 2439–2445 are located at IgFLNa23 strand A’ and at
the preceding 310 helix (Fig. 26B). Highly conserved IgFLN residue L2439 is
located in the middle of the 310 helix pointing into the hydrophobic core of the
domain. Another FLNa deletion mutation causing FMD is 7447del9, which leads to
three-residue (2483–2485) deletion at IgFLNa23 ( 3) (Robertson et al. 2006).
These residues are located at the beginning of strand E. Attempts to record 1H,15N-
HSQC spectrum of 7 and 3 IgFLNa23 failed due to protein aggregation
problems either during protein production and purification or in the NMR samples.
It is likely that these short deletion mutations abolish the folding of IgFLNa23. Full
length FLNa 7 and 3 deletion mutants were shown to eliminate the FLNa
interaction with FilGAP, whereas the L2439M mutation did not affect the
interaction (II: Fig. 7). The 1H,15N-HSQC spectrum of IgFLNa23 L2439M mutant
shows a well-folded domain (II: supplemental Fig. S7) and chemical shift
differences between wild-type IgFLNa23 and the L2439M mutant are located close
to the mutated residue. As the L2439M mutation does not abolish folding of
IgFLNa23 or the interaction with FilGAP, there must be some other physiological
mechanism that produces the phenotype of patients carrying the mutation. The




7.2. Structures of Filamin A Tandem Immunoglobulin-like Domain
Pairs
The structure of IgFLNa19–21 (see Fig. 8) showed that IgFLN domains do not live
in isolation from each other (Lad et al. 2007). These domains can interact and
organize into superstructures which influence each other’s structure and function.
Electron microscopy images of FLNa molecules (see Fig. 9) clearly show that the
IgFLNa domains of rod 2 are more densely packed than would be expected for
linearly arranged IgFLNa domains (Nakamura et al. 2007). By inspecting the
sequence of FLNa, Gorlin et al. noticed that the N-terminal sequences of IgFLNa
domains 16, 18, 20 and 22 are distinct from other IgFLNa domains (Gorlin et al.
1990). The structures of IgFLNb/c domains 16 and 18 are available in the PDB
database (see Table 4). They all seem to lack the strand A of the conventional
IgFLN fold—just as domain 20 does in the structure of IgFLNa19–21.
We wanted to find out whether IgFLNa domain pairs 16–17 and 18–19
share the domain packing mode of IgFLNa20–21 (IV). As the first step of our
study, we compared the SAXS data of IgFLNa constructs 12–13, 16–17, 18–19,
20–21, and 22–23 (IV: Fig. 2–3 and Table 1). The construct containing domains
12–13, which are predicted to behave as two independent modules just linked
together with a flexible linker, was included as a negative control. The SAXS curve
of IgFLNa12–13 conformed well to dimensions of two linearly arranged
conventional IgFLN domains. The dimensions of IgFLNa22–23 were similar to the
dimensions of domain pair 12–13, which indicated that these domains do not form a
compactly packed pair like domains 20–21. However, the dimensions of
IgFLNa16–17 and 18–19 were similar to IgFLNa20–21 which implies that these
domains do indeed form a compact domain pair. We studied the atomic structures
of IgFLNa16–17 and IgFLNa18–19 using NMR spectroscopy (III and IV).
7.2.1. Filamin A Immunoglobulin-like Domain Pair 18–19
Chemical shift assignment, and later also structure determination, of IgFLNa18–19
was complicated by the fact that there were several signals missing from the 1H,15N-
HSQC  spectrum  (III: Fig. 1). Most of the missing signals are located at the N-
terminal part of IgFLNa18 (S1961, H1962, L1963, V1965, G1966, A1969) and at
the domain linker (S2040, Q2041, S2042, E2043, I2044). However, nearly all CHn
groups were visible in the 1H,13C-HSQC spectrum and their chemical shifts were
assigned. Chemical shift assignments of IgFLNa18–19 have been deposited in
BMRB under accession code 15925. Our first step in revealing potential domain–
domain contacts was to compare the 1H,15N-HSQC spectra of the isolated IgFLN
domains to the double-domain construct (Fig. 27). It was immediately obvious from
the spectrum overlay that there are interactions between the domains. We also had
1H,15N-HSQC assignments for isolated single IgFLNa domains 18 (FLNa residues
1954–2045) and 19 (FLNa residues 2046–2141). When chemical shift differences
were plotted as a function of sequence, it was noted that the interaction between
domains 18–19 resembled the domain interaction of IgFLNa20–21 (IV:
supplemental Fig. S3). There were major chemical shift differences at IgFLNa19
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strands C and D, similar to NMR titration of IgFLNa21 with IgFLNa20 (Lad et al.
2007: Fig. 3A). Unfortunately, the chemical shift changes at the N-terminal part of
IgFLNa18 could not be tracked as these signals were not visible in the 1H,15N-
HSQC spectrum of IgFLNa18–19. There were also shift changes at the EF loop of
IgFLNa18. The corresponding part of IgFLNa20, however, is not part of the domain
interaction interface in IgFLNa20–21. This implies that there are some differences
in the domain interaction modes of IgFLNa18–19 and 20–21. We also tried to attest
the domain interaction with NMR titrations, but these attempts failed to show any
interaction between the domains. The structure of IgFLNa18–19 will, however,
provide an explanation for this behavior.
Fig. 27 Spectrum comparison demonstrates the interaction between IgFLNa
domains 18 and 19. Superimposition of the 1H,15N-HSQC spectra of isolated
IgFLNa18 (red) and IgFLNa19 (blue) on the spectrum of IgFLNa18–19 double
domain (black) reveals large chemical differences, implying strong domain–domain
interaction between domains 18 and 19.
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The structure of IgFLNa18–19 (FLNa residues 1954–2141) was determined
by using NOE restraints from 13C- and 15N-edited HSQC-NOESY spectra and
backbone dihedral angles derived from backbone secondary chemical shifts (IV).
As there were some complications in the structure calculation regarding the N-
terminal part of IgFLNa18 (see IV: supplemental methods for detailed description
of the structure determination), additional hydrogen bond restraints were used
between IgFLNa18 strand A and IgFLNa19 strand C. Structure quality statistics
(IV: Table 2) show that the structure determination of IgFLN18–19 yielded a good
quality result. Especially the Ramachandran diagram populations reflect a well-
refined structure. Atomic coordinates of IgFLNa18–19 structure ensemble (20
structures) are available in the PDB database (accession code 2K7Q).
The overall domain arrangement of IgFLNa18–19 structure (Fig. 28)
resembles that of IgFLNa20–21 (Lad et al. 2007). The first  strand of IgFLNa18 is
not folded as part of domain 18 but is instead bound as an additional  strand to the
C strand of IgFLNa19. Equally to domain pair 20–21, the domain 18 is stacked
orthogonally to the N-terminal end of domain 19. The average backbone RMSD
from the mean structure for the double-domain (residues 1960–2135) is 1 Å. There
is some fluctuation between the two domains as the coordinate precision of single
domains is better than for the double-domain. Average backbone RMSD from the
mean structure is 0.8 Å for IgFLNa18 (residues 1960–2045) and 0.3 Å for
IgFLNa19 (residues 2046–2135). The inter-domain fluctuation in the coordinates
might be due to real physical movement or alternatively due to structural
imprecision. The domain interaction of IgFLNa18–19 structure is based on 76 inter-
domain NOEs, of which 42 are located between  strand A of domain 18 and the
CD face of domain 19 (IV: supplemental Fig. S2B). The relative domain orientation
of domains 18 and 19 relies on relatively few inter-domain NOEs and most of them
are housed by a single residue, Y2077.
Despite the similar arrangement of the two domains in IgFLNa20–21 (Lad
et al. 2007) and IgFLNa18–19, the details of domain interaction are completely
different. The absence of  strand A leaves the hydrophobic core of domain 18
partly exposed. The side chain of Y2077 is pointing outwards from the BC loop of
IgFLNa19 and it sticks into the hydrophobic core of domain 18, attaching the
domains together (Fig. 28C). This domain–domain interaction is totally different
from IgFLNa20–21 where the domain interaction is mainly determined by the 
strand interaction between IgFLNa20 strand G and the BC loop of IgFLNa21 (Fig.
8). The relative domain orientations also differ substantially in these two domain
pairs (IV: Fig. 7). On this account the domain linkers and the AB loops of the even-
numbered domains take completely different paths in the two structures. In
IgFLNa18–19, both the domain linker and the AB loop of domain 18 participate in
the domain interface (Fig. 28C). In contrast, in IgFLNa20–21 the AB loop of
domain 20 and the domain linker are exposed to solvent (Fig. 8). In addition, the
IgFLNa18 EF loop, housing the hydrophobic residues (F2011, P2013) in contact
with the side chain of Y2077, is an important part of the domain interface, which
explains the chemical shift differences observed in this area (IV: supplemental Fig.
S3). The crucial role of the domain linker in the domain interaction of IgFLNa18–
19 explains why our attempts to demonstrate the domain–domain interaction using
NMR titrations failed: the extra residues introduced to the N-terminal end of
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domain 19 in protein production disturb the interaction interface. Linking the
domains together also increases the effective concentration of the domains
enhancing the interaction.
Fig. 28 The solution structure of IgFLNa18–19 (PDB accession code 2K7Q) (IV).
Panels (A) and (B) show the structure from the same perspective. Panel (C) shows
the opposite view to pick out the essentials of domain–domain interaction. Domains
(defined by the sequence) are differentially colored: 18, blue; 19, red. (A)
Superimposed backbone traces of the 20 substructures. Superposition was done
using residues 1960–2135. (B) Secondary structure elements of the mean structure.
(C) Y2077 is the main determinant of the domain–domain interaction between
IgFLNa domain 18 and 19. Reprinted and adapted with permission from (IV).  ©
2009 The American Society for Biochemistry and Molecular Biology.
We measured the backbone 15N  R1 and  R2 relaxation  rates  and  {1H}–15N
heteronuclear NOEs to elucidate the dynamicity of IgFLNa18–19, and also to verify
the structure of IgFLNa18–19. The relaxation rates of IgFLNa18–19 (IV:
supplemental Fig. S7) are in the expected range for a 20-kDa tightly-folded protein.
Relaxation analysis was complicated by many overlapping and missing 1H,15N-
HSQC signals especially in those areas which would have been the most interesting,
i.e., at the IgFLNa18 strand A and at the domain linker. The relaxation data accords
with the domain association model of IgFLNa18–19, where the N-terminal part of
domain 18 is bound to the domain 19 and the two domains are tightly bound
together. Observed relaxation rates imply a compact domain pairing and do not
reveal any highly flexible loops or long tails. We attempted to carry out full model-
free analysis of the relaxation data, but successful analysis was hampered,




IgFLNa18–19 Interaction with 7 Integrin and Dopamine Receptors
IgFLNa19 is known to participate in the interaction between FLNa and integrin
tails, even if the main integrin binding site is located at domain 21 (see Chapter
3.3.2). With similarity to IgFLNa20–21 (Lad et al. 2007), the first  strand of
IgFLNa18 is blocking the integrin binding site at the C strand of domain 19. It has
been shown that the presence of IgFLNa20 strand A effectively blocks the integrin
binding site of domain 21, inhibiting integrin binding, even if integrin tails are able
to displace strand A of domain 20 from domain 21 to some extent (Lad et al. 2007).
Integrin tails bind to IgFLNa18–19 even if binding is weaker than to isolated
domain 19. We tested the interaction between IgFLNa18–19 and integrin 7 peptide
(Ac-776PLYKSAITTTINP788-NH2) using NMR titrations (IV: supplemental
methods and supplemental Fig. S4). In our experiments we could not detect
interaction between integrin 7 peptide and IgFLNa18–19; even when under
equivalent conditions the peptide clearly interacted with the strand C of isolated
IgFLNa19. This confirms that IgFLNa18 strand A is able to at least inhibit, if not
totally block, the interaction between IgFLNa and integrin 7.
IgFLNa19 has also been proven to be the binding site for dopamine
receptors D2 and  D3 (see Chapter 3.3.2) (Lin et al. 2001). The point mutation
experiments of Lin et al. showed that the interaction site is located at the CD face of
domain 19 (Lin et al. 2002). FLNa binding site has been mapped to the third
intracellular loop of the dopamine receptor, i.e., to the D2 and D3 residues 211–344
and 211–227, respectively. When we compared these residues, we noted highly
conserved sequences, which contain a polyarginine repeat resembling the N-
terminal sequence of IgFLNa20 (Fig. 29).
Fig. 29 The dopamine receptor peptides tested for interaction with IgFLNa18–19.
We wanted to confirm the dopamine receptor binding site at IgFLNa19 and
to see whether dopamine receptor peptides are able to displace the IgFLNa18 strand
A from the CD face of domain 19. We performed NMR titrations of IgFLNa18–19
using dopamine receptor peptides described in Fig. 29 (unpublished results). The
titration results are presented in Fig. 30. Both D2 and  D3 peptides interacted with
IgFLNa18–19 with high affinity and were able to displace the strand A of
IgFLNa18 from the CD face of IgFLNa19. The binding site for dopamine receptors
is located at the CD face of domain 19. Some chemical shift changes are also found
at the residues of domain 18. All affected residues are located close to CD face of
domain 19. This verifies the dopamine receptor interaction site at the CD face of
IgFLNa19 and suggests that this interaction also follows the general interaction
mode of IgFLN domains. A more detailed view of the interaction could be gained
from a complex structure of IgFLNa19 and dopamine receptor peptide.
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Fig. 30 Dopamine receptors D2 and  D3 interact with the CD face of IgFLNa19.
IgFLNa18–19 was titrated with the peptides derived from the third intracellular
loop of dopamine receptors D2 and  D3 (Fig. 29). Spectrum overlay reveals the
residues with chemical shift changes: black, IgFLNa18–19 in the absence of
ligands; magenta, 1.6:1 D2-to-IgFLNa18–19; cyan, 1.6:1 D3-to-FLNa18–19. Both
peptides bind to the same site with similar affinities. Inset shows the location of the
residues with affected resonances.
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7.2.2. Filamin A Immunoglobulin-like Domain Pair 16–17
The spectra of IgFLNa16–17 were remarkably good (III: Fig. 1B). All cross-peaks
except K1801, G1866 and Q1916 were visible in the 1H,15N-HSQC spectrum and
essentially complete backbone and side chain assignments were attained (BMRB
accession code 15924). As we already had assignments for IgFLNa17 (see Chapter
7.1.1), we compared the chemical shifts of domain 17 in isolation and in the
IgFLNa16–17 domain pair. We expected to see something comparable to the
changes of IgFLNa19 and 21, but the results were rather the opposite (III: Fig. 2).
All chemical shift changes were located at the AG face of domain 17 and the
resonances of the CD face remained practically unchanged. This implied that the
domain–domain interaction mode of domains 16 and 17 is drastically different from
IgFLNa18–19 and 20–21.
Structure determination of IgFLNa16–17 (FLNa residues 1772–1956) was
relatively straightforward owing to good spectrum quality and yielded a structure of
excellent quality (IV). NOE restraints from 13C- and 15N-edited HSQC-NOESY
spectra and chemical shift-based backbone dihedral angle restraints were used as
constraints in the structure calculation. Both Ramachandran map populations and
coordinate precision indicate successful structure determination (IV:  Table  2).
Atomic coordinates of IgFLNa16–17 structure ensemble (40 structures) are
available in the PDB database (accession number 2K7P). Ninety-nine inter-domain
distance restraints were found (IV: supplemental Fig. S2A), and all of them were
located between  strands A and G of IgFLNa17 and B and G of IgFLNa16. These
were enough to define the inter-domain orientation in comparable precision to the
individual domains.
As in IgFLNa18 and 20, the first predicted  strand of domain 16 does not
fold as in conventional IgFLNs. Residues 1772–1785, corresponding to  strand A
of IgFLNa16, lack long range distance restraints and do not hold any regular
secondary structure (Fig. 31). Due to missing strand A, the hydrophobic core of
domain 16 is exposed, and it binds tightly to the AG face of domain 17. The two
IgFLN domains are stacked on to each other so that their  sheets are approximately
parallel. The domain interaction is mostly based on hydrophobic interactions. The
side chains of H1877 and T1876 from IgFLNa17 are located particularly close to
the exposed hydrophobic core of IgFLNa16 (Phe1791, Leu1793, Ile1795, Leu1856,
and Phe1858) (IV: Fig. 5C). There are several hydrophobic and aromatic residues at
the AG surface of IgFLNa17, much more than in the corresponding parts of
domains 19 and 21 (Fig. 22 and IV: supplemental Fig. S1), which establishes
prerequisites for the domain interaction of IgFLNa16–17. The structure of domain
17 in IgFLNa16–17 is remarkably similar to the structure of isolated IgFLNa17. In
fact it is somewhat surprising that the solubility of isolated IgFLNa17, with
relatively hydrophobic exposed AG face, was sufficient for successful NMR
studies. In conclusion, the structure of IgFLNa16–17 revealed a novel domain–
domain interaction mode of IgFLNs.
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Fig. 31 The solution structure of IgFLNa16–17 (PDB accession code 2K7P) (IV).
Panels (A) and (B) show the structure from the same perspective. Panel (C) shows a
top view through domain 16 to pick out the essentials of the domain interaction.
Domains are colored as: 16, green; 17, gray. (A) Superimposed backbone traces of
the 40 substructures. Superimposition was done using residues 1787–1954. (B)
Secondary structure elements of the mean structure. (C) Exposed hydrophobic core
of IgFLNa16 stacks on to the AG face of domain 17. Residues of the domain
interface are represented with stick models. Reprinted and adapted with permission
from (IV). © 2009 The American Society for Biochemistry and Molecular Biology.
In order to characterize the dynamic behavior of IgFLNa16–17 we
measured the backbone 15N R1 and R2 relaxation rates and {1H}–15N heteronuclear
NOEs. There were some overlapping 1H,15N-HSQC signals which hindered
relaxation analysis of those residues, but overall almost complete relaxation data
was achieved (IV: supplemental Fig. S6). Measured relaxation rates conform well
to the characteristic values of 20-kDa globular proteins. Relaxation analysis clearly
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shows that the N-terminal residues of domain 16 undergo rapid motions, which
confirms that IgFLNa16 strand A is unfolded. R2 relaxation rates and heteronuclear
NOEs have a slight decrease at the BC loop of IgFLNa17, indicating that this loop
is more flexible than the rest of the structure. Coordinate precision of this loop is,
however, almost as good as at other parts of the structure even if it was somewhat
floppy in the structure of isolated IgFLNa17 (see Fig. 22). In conclusion, the
relaxation analysis along with the abundance of inter-domain NOEs and the
excellent spectrum quality, support the view that the two domains of IgFLNa16–17
are tightly bound together.
Interaction of IgFLNa16–17 with GPIb
We had previously shown that glycoprotein Ib  binds to the CD face of
IgFLNa17 (I) and we also verified the interaction with NMR titrations (see Fig. 23).
As the CD face of domain 17 is free in IgFLNa16–17 and essentially structurally
identical to isolated IgFLNa17, we were confident that GPIb  also binds to
IgFLNa16–17. To confirm the interaction we performed NMR titration of
IgFLNa16–17 with GPIb 556–577 peptide. The results of the titration are
comparable to the ones achieved with isolated IgFLNa17 (IV: supplemental Fig.
S5). The strength of the interaction was further verified with biochemical
experiments (IV: Fig. 6).
Potential Influence of Domain 15 and Hinge 1 on Structure of IgFLNa16–17
The peculiar structure of IgFLNa16–17 raised questions about whether the presence
of domain 15 or H1 preceding domain 16 could have any effect on the domain
interaction of IgFLNa16–17. The structure of IgFLNb15 (PDB code 2DMB) shows
a conventional IgFLN fold, but nothing is known about the structure of H1. We
compared the 1H,15N-HSQC spectra of IgFLNa15–17 and IgFLNa16–17 to see if
the residues of domains 16–17 undergo any chemical shift changes (unpublished
results). 1H,15N-spectrum of IgFLNa15–17 shows >250 well-resolved backbone
signals of which around one-third have higher intensity and narrower line-width.
Spectrum comparison shows that the chemical shifts of domains 16–17 are
essentially the same in both IgFLNa15–17 and IgFLNa16–17 constructs (Fig. 32).
This indicates that the folding pattern of IgFLNa16–17 pair is also retained in this
longer construct and IgFLNa15 or H1 do not interact with this domain pair. There
are some minor changes at 16–17 linker (e.g., residue H1867) and at BC loop of
IgFLNa17 (e.g., residue T1890). These are presumably due to slightly different
experimental conditions which have the most pronounced effect on the resonances
of these flexible loops. It is also evident that the cross-peaks belonging to domain
pair 16–17 are considerably broader than the rest of the peaks, indicating faster
transverse relaxation. This confirms that domain 15 behaves independently on
domains 16–17—it is just linked to them with a flexible linker H1. We are planning
to sequentially assign the spectra of IgFLNa15–17 and to measure the {1H}–15N
heteronuclear NOEs to find out if H1 has some structured parts or whether it is just
a flexible linker sequence.
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Fig. 32 1H,15N-HSQC spectrum comparison of IgFLNa15–17 (blue) and
IgFLNa16–17 (red) shows that domain 15 or H1 do not interact with the domain
pair 16–17. Also, the narrow line-width of the signals of domain 15 support the
conclusion that domain 15 behaves independently from the domain pair 16–17.
Resonance assignments of IgFLNa16–17 signals are shown.
7.2.3. Similarities and Differences of the Three IgFLNa Domain Pairs
The three IgFLNa domain pair structures characterized so far have all surprised us
with new structural features. There are two common denominators of the three
domain pairs IgFLNa16–17, IgFLNa18–19, and IgFLNa20–21: (i) the two domains
interact tightly with each other and form relatively compact structures, and (ii) the 
strand A of the even-numbered domain is not folded with its own domain but is
either unstructured (IgFLNa16) or folds together with the following domain
(IgFLNa18–19 and IgFLNa20–21). If one dissects the structures in more detail,
some additional similarities can be found. In all three domain pairs the strand D of
the even-numbered domain is split into two parts: beginning of strand D is part of 
sheet CFG and D’ makes a  strand interaction with strand E (Fig. 28; Fig. 31; Fig.
33; Lad et al. 2007). In conventional IgFLN domains, and also in the odd-numbered
domains of the domain pairs, the strand D is continuous and binds next to the strand
E. Another unifying trait of the even-numbered domains is that the tyrosine corner
(Hemmingsen et al. 1994), one of the highly conserved features in the Ig-like
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domains, is replaced by histidine (H1840, H2019 and H2210)
numbered domains of all three domain pairs the corresponding residue is tyrosine
(Y1932, Y2114 and Y2305). Chemical shifts of H18
that these histidines are protonated at the nitro
the more infrequent histidines tautomer. Sequence alignment of IgFLN domains
(van der Flier and Sonnenberg 2001b) shows that the tyrosine corner is
replaced by histidine in domains 1, 2, 5 and
on isoform by histidine or some other residue in domains 7 and
domains 11 and 22 are available in the PDB database and they also have
discontinuous D strand, but otherwise the structures seem to be ful
domains.
Fig. 33 The odd-numbered domains of the IgFLNa
20–21 have discontinuous strand D and protonated histidine replacing the tyrosine
corner. The structure of IgFLNa16 is shown he
represented with a stick model. Blue, strand D; red,
Despite these similarities it is obvious that all three IgFLN domain pairs are
remarkably different and no general pattern of
was recognized. Sequence comparison of IgFLN domains
some of the key residues involved in domain interaction
human filamin isoforms and also in filamins of other organisms (
supplemental Fig. S1). It seems that the concept of th
C-terminal end of filamins could be evolutionally conserved because
has specific functions in regulating protein binding to filamins.
 (Fig. 33). In odd-
40 and H2019 (III) indicate
gen of the imidazole ring, which is
also




 domain pairs 16–17, 18–19, and
re as an example. H1840 is
 strand D’.
IgFLN domain–domain interaction
, however, shows that
s have been conserved in all
IV: Fig. 4 and




7.3. Domain Organization in Filamin A Immunoglobulin-like Domains
16–21
After unveiling the structures of the IgFLNa domain pairs 16–17, 18–19, and 20–
21, it became obvious that IgFLNa domains 16–21 are forced to pack into a
compact cluster of domains. In their recent article, Kesner et al. presented a
homology modeling-based full-length filamin model that includes the compact
packing of domain pairs 18–19 and 20–21 (Kesner et al. 2009b). Even if it roughly
matches with the experimentally detected dimensions of filamin dimers, this
sketchy structure model is not able to provide details on domain interactions and it
fails to reproduce the compact domain packing of IgFLNa16–17. We wanted to
characterize the structure of IgFLNa16–21 domain sextet to find out whether the
domain pairs also remain intact in this larger construct, and what the consequences
of dense domain packing for FLNa interactions might be. As previous attempts to
crystallize IgFLNa16–21 had not succeeded, we decided to look into the structure
of this 60-kDa protein using NMR spectroscopy (V). Residual dipolar couplings
provide ideal conformational restraints for NMR studies of protein domain
organization of large modular systems (Fischer et al. 1999; Skrynnikov 2004;
Blackledge 2005).
Due to the high molecular weight of IgFLNa16–21 (FLNa residues 1772–
2329), perdeuteration of the protein was mandatory to suppress extensive transverse
relaxation. Triply-labeled (2H,13C,15N-labeling) sample of IgFLNa16–21 was
produced for resonance assignment and measurement of RDC restraints. As there
are no deeply buried areas in this protein, sufficient deuterium–proton exchange
was attained simply by buffer exchange, eliminating the need for elaborate sample
pretreatment and protein denaturation. The overall transverse relaxation rate of
2H,13C,15N-IgFLNa16–21 was in the range of 30–40 s 1, which necessitated the use
of TROSY-based NMR experiments in the sequential assignment, in the relaxation
measurements, and in determination of residual dipolar couplings. With the
TROSY-based experiments, however, a relatively good and complete NMR dataset
was gained.
The 1H,15N-HSQC-TROSY spectrum of triply-labeled IgFLNa16–21 shows
approximately 450 well-resolved cross-peaks with relatively uniform intensities,
and assignments were found for 88% of the 514 non-proline residues of IgFLNa16–
21 (V: Fig. 3). To find out whether the three domain pairs specifically interact with
each other in the larger constructs and to locate the interaction sites, we compared
the 1H,15N-HSQC spectra of the isolated IgFLNa domain pairs 16–17, 18–19, and
20–21 with the spectrum of IgFLNa16–21 (Fig. 34). The spectrum of IgFLNa16–21
is almost the sum of its subcomponents and most of the signals have retained their
locations. The similarity of the spectra was of great help in the sequential
assignment of IgFLNa16–21. Assignment from scratch would not have been
feasible, or at least it would have been extremely challenging. Clearly, no dramatic
structural differences are present between IgFLNa16–21 and its isolated
substructures. Closer inspection of the chemical shift differences gave clues about
the domain interaction interfaces (V: Fig. 5). In general, not many chemical shift
differences can be detected between the domain pairs and the IgFLNa16–21. The
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only significant differences are found in domains 19 and 21. The absence of major
chemical shift differences suggests that the interactions between the domain pairs
are rather weak and the domain organization of the IgFLNa16–21 is mainly
determined by the covalent linkages of the short linker sequences between the
domains.
Fig. 34 Superimposition of the 1H,15N-HSQC-TROSY spectrum of 2H,13C,15N-
IgFLNa16–21 (black) and the 1H,15N-HSQC spectrum of IgFLNa16–17 (red),
IgFLNa18–19 (blue), and IgFLNa20–21 (yellow) (V). The structures of the isolated
domain pairs are shown in the inset.
The calculated pI of IgFLNa16–21 is 5.7 making it negatively charged in
the sample pH of 6.8. Negatively charged Pf1 phages (Hansen et al. 1998) were
thus chosen to introduce residual alignment into the IgFLNa16–21 sample for the
RDC determination. The scalar and residual dipolar couplings between the amide
proton (1HN)  and  nitrogen  (15N) were measured using three-dimensional HNCO-
TROSY-based triple-resonance experiment (Yang et al. 1999; Kontaxis et al. 2000,
Permi et al. 2000). Backbone amide 1HN–15N RDCs were determined in total for
430 residues. The distribution of RDCs indicated that the alignment was stronger
for domains 20–21 than for domains 16–19 (V: Fig. 6).
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For rigid-body modeling of the IgFLNa16–21 domain organization, an
arbitrary starting structure was built using the structures of IgFLNa domain pairs
16–17, 18–19 and 20–21 by superimposing the overlapping parts of the
substructures (IV; Lad et al. 2007). We first attempted to carry out the alignment
tensor fitting and the determination of domain pair orientations with three modules
formed from domain pairs 16–17, 18–19, and 20–21. It, however, turned out to be
impossible to find the proper fit of the RDCs in this way. There were no problems
in domain pair 16–17, but domain pair 18–19 and especially 20–21 yielded poor fits
of the RDCs. We supposed that this could be an indication of the altered domain
orientations of the double-domains. Thus, we fitted the RDCs using six modules
composed of individual domains (Fig. 35).
The closely similar alignment tensors of domains 16 and 17 confirm that
these domains form a compact tightly packed domain pair, and the domain
orientation determined by the NOE restraints is close to the real structure (Fig. 35).
A slight adjustment of the domain orientation was suggested by the alignment
tensors (V: Fig. 9A). The domain orientations in domain pairs 18–19 and 20–21
required closer inspection, as in these domain pairs, the alignment tensors of the
two domains seem to be different. The alignment tensor components of domain 18
are of a smaller magnitude than for domain 19, suggesting that domain 18 wobbles
slightly relative to domain 19. Alignment of the tensor axes twists domain 18 to a
slightly more open conformation relative to domain 19 (V: Fig. 9B). Obviously, the
low number of inter-domain NOE restraints between domains 18 and 19 was not
quite enough to determine the domain orientation with high accuracy (see Chapter
7.2.1). The inter-domain orientation of domain pair 20–21 was affected even more
by the alignment of the tensors (V: Fig. 9C). Relative to domain 21, domain 20 is
twisted along its longitudinal axis and turns more towards domain 21. As the
chemical shifts of domains 20 and 21 are very similar in the isolated double domain
20–21 and IgFLNa16–21, the domain orientation cannot be markedly affected by
the presence of other domains. According to the RDC data, the domain arrangement
in solution differs from the orientation seen in the crystal structure. Interestingly,
the molecular dynamics simulations performed by Lad et al. for the structure of
IgFLNa19–21 to see whether the crystal contacts had affected the structure, gave
structure alterations that were similar to those in as our RDC analysis (Lad et al.
2007).
Parallelization of the alignment tensors and selection between the
combinations of degenerate orientations produced a clover-leaf-shaped organization
of the three domain pairs (Fig. 35B). The compact shape and dimensions
(maximum dimension approximately 100 Å) of the IgFLNa16–21 structure model
match nicely with the previously published electron microscopy images of the
IgFLNa constructs (Nakamura et al. 2007). In this domain organization mode, the
interaction  sites  at  the  CD  faces  of  domains  17,  19  and  21  are  freely  exposed  to
solvent, and available for interactions.
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Fig. 35 Rigid-body modeling of the IgFLNa16–21 domain orientations using RDC
restraints (V). Separate modules are color coded as: yellow, domain 16; light blue,
domain 17; orange, domain 19 and the A strand of domain 18; red, domain 18;
green, domain 21 and the A strand of domain 20; navy, domain 20. (A) Arbitrary
structure of IgFLNa16–21 showing the alignment tensors of modules. (B)
Parallelized alignment tensors. The figure shows one plausible combination of
degenerate orientations that fulfills covalent and non-covalent structural confines
and chemical shift data. The figures were created with the MODULE program
(Dosset et al. 2001).
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To characterize its dynamic behavior we measured the backbone amide 15N
R1 and R2 relaxation rates and {1HN}15N heteronuclear NOEs of IgFLNa16–21 (V:
Fig. 8). Some differences can be noted in the relaxation properties of the different
domains. Domain pair 16–17 has on average slower transverse relaxation than
domain pairs 18–19 and 20–21, which suggests that domain pair 16–17 is more
dynamic than the other two domain pairs. The flexibility of domain pair 16–17
enables it to give way for the interaction partners to bind to the CD faces of the odd-
numbered domains. Faster transverse relaxation in domain pairs 18–19 and 20–21
implies that these domain pairs could be bound together as they exhibit relaxation
properties of a larger unit than domain pair 16–17. There is, however, some
flexibility between domain pairs 18–19 and 20–21, as the alignment tensors of these
domains are not equal. Except for the 15 N-terminal residues, the relaxation
properties of domains 16 and 17 are similar, which confirms that the domains form
a compact domain pair. The relaxation properties of the even- and odd-numbered
domains of domain pairs 18–19 and 20–21 are more distinct. In general, the even-
numbered domains seem to have somewhat reduced heteronuclear NOEs than the
odd-numbered domains and have regions with elevated R1 (especially domain 18)
and lowered R2 (domain 20). Altered relaxation properties indicate that the fold of
the domains 18 and 20 is not as fixed as folding in other domains. Similar behavior
of these domains was noted in structures of the isolated domain pairs (IV; Lad et al.
2007).
Even if the changes in the domain orientations produced by RDC analysis
are notable, the structural details of the domain interactions could also be, in
principle, fulfilled in these domain conformations. However, more elaborate
analysis and refinement of the structures are needed to focus on the structural
details as the rigid-body modeling performed here is only a crude way to model the
domain orientations. The A strands of domains 18 and 20 escaped detailed analysis
as their signals were not visible in the spectra. As these parts of the protein are more
flexible, it is possible that the A strands of domains 18 and 20 are detached from the
corresponding even-numbered domains in this larger construct. This would allow
large freedom in domain arrangement. The chemical shift and relaxation data of
IgFLNa16–21, however, suggest that the A strands of domains 18 and 20 remain
bound to the CD face of domains 19 and 21, respectively.
Another phenomenon becoming available in the aligned protein samples is
the residual anisotropy of the carbonyl chemical shift (Cornilescu et al. 1998).
These effects can be also used as structural restraints in the refinement of protein
structures. We detected a clear trend comparable with the RDCs in the changes of
amide carbonyl chemical shifts between the isotropic and anisotropic sample, but
the resolution of the HNCO-TROSY spectra in the carbon dimension was not
sufficient to provide reliable restraints.
The structural characterization of IgFLNa16–21 could be further elaborated
by refining the starting structures against the RDCs and NOE restraints
simultaneously. Only NOEs between the exchanging protons (in practice, the
backbone amides) can be recorded for perdeuterated IgFLNa16–21, and laborious
selective labeling approaches should be used to obtain more NOE restraints.
Extensive transverse relaxation and dynamicity of the domain interactions might,
however, prevent detection of the inter-domain NOEs. A more fruitful approach to
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refine the structure model would be combination of RDC and small-angle X-ray
scattering (SAXS) restraints (Mattinen et al. 2002; Grishaev et al. 2005; Gabel et
al. 2008). SAXS provides information on the dimensions of the protein, nicely
complementing the orientational information gained from RDCs. In this particular
case, SAXS would help in determining the integrity of the domain interactions and
in fixing the positions of the domain pairs relative to each other.
7.4. Implications of Our Structural Findings for Filamin Functions
The structures of the IgFLNa domains 17, 19 and 23 all have traditional IgFLN fold
and they closely resemble each other and domain 21 with average pairwise C
RMSD of ~1.2 Å (I, II, IV). All filamin protein–protein interactions studied were
discovered to take place through the same interaction mechanism—binding of the
extended peptide as an additional  strand next to the C strand of the domain in
question. Both the sequences of the interacting peptides, and the sequences of the
IgFLNa domains seem to have some homology. Similarities of the interaction
partners open up a possibility that the interactions can be at least partly
indiscriminate. Ithychanda et al. have recently shown that IgFLNa domains 4, 9, 12,
17, 19, 21 and 23 form a homologous subgroup of IgFLNa domains and GPIb ,
integrin 7, and migfilin peptides can all bind to several of these domains
(Ithychanda et al. 2009b). The authors speculated that simultaneous binding to
several IgFLN domains could promote receptor clustering. However, it should be
noted that these studies were done with isolated single IgFLN domains and in full-
length filamin the situation might be different. Our structural findings clearly
indicate that IgFLN domains can exert an influence on the interactions and function
of their fellow domains. The A strands of IgFLNa domains 18 and 20 block the
protein binding site at the following domain and hinder the interactions at these
binding sites. In full length filamin the inter-domain contacts can have even more
complex consequences for the interactions and the function of the protein. IgFLN
domains do not live in isolation, and thus should not be studied as such without
further consideration of the effect of domain–domain interactions. In light of
domain promiscuity of the filamin interactions, the FLN isoform selectivity seen
with FilGAP is remarkable. Subtle differences in the structure of the CD face of
IgFLN domain 23 discriminate between the isoforms so that only FLNa, but not
FLNb or FLNc, binds to FilGAP (II).
IgFLNa domain pairs 16–17, 18–19 and 20–21 all have peculiar domain–
domain interaction modes. Filamins have been speculated to be involved in
mechanosensory signaling (Johnson et al. 2007) and IgFLN domain pairing could,
in principle, act as a sensor for mechanical force. Pentikäinen and Ylänne have
studied the effect of mechanical force on folding of IgFLNa domain pairs 18–19
and 20–21 using steered molecular dynamics simulations (Pentikäinen and Ylänne
2009). They noted that the A strands of the even-numbered domains detached
relatively easily from the CD faces of the corresponding odd-numbered domains,
exposing the binding sites for filamin interaction partners without disturbing the
overall folding of the domains. Further stretching caused partial unfolding of the
even-numbered domain, elongating the domain pair. Reversible dissolution of
domain interaction and unfolding of the domains could act as a mechanism
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introducing elasticity to filamin–actin networks. Domain interaction between
IgFLNa domains 16–17 appears tighter than in other domain pairs and it is not
interfering with the interaction site at the CD face. The function of this domain
interaction is not obvious from the structure alone. The large planar surface formed
by the parallel  sheets could in principle serve as a docking site for protein–protein
interactions and there are some clefts at the domain interface that could be imagined
to function as binding sites for small ligands. This is, however, only speculation.
Relatively compact dimensions of the filamin rod domain 2 are nicely
explained by the tight domain packing of IgFLNa16–21 domain sextet (V). These
domains form a cluster of domains having maximum dimension of 100 Å. IgFLNa
domains 16–21 contain interaction sites for several filamin interaction partners (see
Table 5). Domain contacts in IgFLNa16–21 can have considerable effects on
filamin interactions mediated by these domains. Close domain packing can block
access to interaction sites. Liberation of domain contacts through detachment of the
A strands of domains 18 or 20 from the CD face of the corresponding odd-
numbered domain by one interaction partner could open up the domain cluster to
reveal other interaction sites buried in the domain interfaces. It is also possible that
the A strands of domains 18 and 20 could swap between the CD faces of different
odd-numbered domains, raising the complexity of domain organization even more.
It is intriguing that domains 16–21 house numerous filamin interaction sites
but only a few disease-causing filamin mutations have been found in these domains
(Table 3). There could be two opposing explanations for this: either these
interactions are not that essential for normal human physiology, making the
mutations irrelevant; or mutations in these domains cause devastating consequences




This project is a demonstration of the power and versatility of NMR spectroscopy in
studies of modular proteins. In order to fully understand the structure, interactions
and function of multi-domain proteins, one needs to know the structure of the entire
system. Even if it is harder and more time-consuming, protein structure
determination projects should turn their focus from isolated single domains to larger
systems.  This  is  unlikely  to  lead  to  greater  success  in  terms  of  number  of  PDB
entries, but will certainly provide richer and more informative structural data.
We have used a bottom-up approach to elucidate the architecture of filamin
A immunoglobulin-like domains. We started the project by studying single IgFLN
domains and their interactions. As a lot of structural data is available on isolated
FLN domains, we wanted to move from single domains to larger systems. This
approach was successful as we were able to reveal the structures of two novel
filamin domain pairs. As a final challenge, we wanted to see the big picture: we
used NMR spectroscopy to find out how the three filamin domain pairs arrange
themselves into even higher superstructures. This is still work in progress, but it has
already provided clues on the structural organization of 60-kDa multi-domain
IgFLNa16–21 housing binding sites for several interaction partners of filamins.
This study has certainly made clear that filamin immunoglobulin-like domains, like
most protein modules, are more than just beads on a string.
“An expert is one who knows
more and more about less and less.”
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